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ABSTRACT
MEASURING PARALYTIC SHELLFISH TOXINS IN MUSSELS
FROM NEW HAMPSHIRE COASTAL WATERS
USING ZWITTERIONIC HYDROPHILIC LIQUID CHROMATOGRAPHY/
ELECTROSPRAY MASS SPECTROMETRY
by
Lee Lee Chung
University of New Hampshire, May, 2010
A liquid chromatography/mass spectrometry method (LC/MS) has been
adapted from the literature to provide a rapid, direct and highly sensitive routine
assays for several Paralytic Shellfish Poisoning (PSP) toxins, with detection limits
in the ppb range for STX and its analog neosaxitoxin (NEO) and decarbamoyl
saxitoxin (dcSTX). A high throughput sample clean-up aided in reducing the
effects of the matrix. Method validation and stability studies have been performed
to show that reliable results are produced by this LC/MS method. The LC/MS
method was found to supplement the mouse bioassay with the ability to
determine the levels and specific types of toxins in mussels. Toxin profiles were
developed for two mussel sampling sites in NH during the summer of 2009. The
most prevalent of the PSP toxins found were STX and NEO. In addition, one
mussel sample which contained a higher level of these PSP toxins was also
found to contain gonyautoxin-1, -2, -3 and -4 (GTX) toxins.

1

CHAPTER 1

INTRODUCTION

1.1 Red Tide and Shellfish Toxins
Red tide, so-called Harmful Algae Bloom (HAB), occurs when marine
algae rapidly reproduce resulting in water discoloration (6; 7). Red tide is
believed to be caused by increased sunlight and nutrient loading which are
driven by both anthropogenic and natural activities in the ocean (8). Algae are
floating single-celled organisms that act as a primary food source at the very
beginning of the food chain (9; 10). Algae grow by photosynthesis through the
absorption of sunlight and eventually serve as the source of nourishment for
heterotrophic organisms. These toxin-containing algae reproduce in biomass and
pass on toxins to higher trophic levels in the ocean. Shellfish such as mussels,
oysters and clams are filter-feeding bivalves, which ingest microalgal cultures
and accumulate toxins in their bodies (11). Animals that consume these shellfish
such as birds, land animals and humans, are all ultimately affected. High levels
of toxin consumption can cause a variety of life threatening illnesses in humans
(12).
There are several types of shellfish poisoning that are categorized as food
borne illnesses (13), including Paralytic Shellfish Poisoning (PSP), Neurotoxic
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Shellfish Poisoning (NSP), Amnesic Shellfish Poisoning (ASP) and Diarrhetic
Shellfish Poisoning (DSP). PSP results from consumption of shellfish
contaminated with water-soluble neurotoxic alkaloids, including saxitoxin (STX),
as well as 17 other related analogs (14; 15). NSP results from the consumption
of contaminated shellfish with lipid soluble polycyclic polyether toxins, called
brevetoxins (16). ASP is caused by consumption of shellfish that have
accumulated domoic acid, a water soluble amino acid (17). DSP, caused by
ingestion of high molecular weight, lipophilic polyethers (18), is characterized by
incapacitating diarrhea, nausea, vomiting, abdominal cramps, and chills.
In New Hampshire, PSP is a major public health concern (12). It is known
that Alexandrium fundyense, a dinoflagellate, produces PSP toxins that are
ingested and accumulated in shellfish. Alexandrium blooms occur seasonally
from April to October in the Western Gulf of Maine, along the coastlines of Maine,
New Hampshire and Massachusetts (19).
The PSP toxins form a group of closely related tetrahydropurine
compounds that are categorized into three subgroups: i) carbamate (saxitoxin
(STX), neo-saxitoxin (NEO) and gonyautoxins (GTX1-4); ii) N-sulfo-carbamoyl
(GTX 5-6, C1-4); and iii) decarbamoyl- (dcSTX, dcNEO, dcGTX 1-4)
components. The general structures of the 18 known PSP toxins are given in
Figure 1.1. These toxins have three different charged states (0, +1, +2) with four
different functional groups: R-i, R2, R3 and R4 (2). Most of these toxins exist in
their protonated forms in solution. They are stable at lower pH levels, but
decompose rapidly in basic solution (1). They are nonvolatile, thermally labile

and lack chromophores. Each PSP derivative has the ability to disable ionic
conductance thereby affecting the human nervous system (20; 21). The different
toxins bind to the voltage-gated sodium channel site with different affinities
corresponding to differences in subgroups and charges (22; 23) (Table 1.1).
Therefore, each toxin has its own toxicity level with variation in different R groups
(24). Among all of the PSP toxins, STX is the most toxic, followed by GTX 1, and
then NEO. The toxicity factors of the PSP toxins given in Table 1.2 were
determined relative to the toxicity of STX, which is assigned a toxicity factor of 1
(1). STX is the most commonly found toxin among all of the PSP toxins and it is
considered a chemical warfare agent (25; 26). It is also the only calibration
standard used for mouse bioassay testing which will be discussed shortly.
R4.

Ri

H2NT

N

R2

*3

Figure 1.1 .Structure of PSP toxins with four R groups resulting in three different
charged states (1).
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Table 1.1.T ne three m aior group s of PSP toxins differ in t\le R4 subgrou
Carbamoyl, N-sulfo-carbamoyl and decarbamoyl (1).
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Toxin
GTX5(B1)
GTX6 (B2)
C1
C2
C3
C4
dcGTX2
dcGTX3
dcSTX
GTX1
GTX2
GTX3
GTX4
11-hydroxy-STX
NEO
STX
Table 1.2. Toxicity factors

Relative Toxicity
0.0644
0.0644
0.0060
0.0963
0.0133
0.0576
0.1538
0.3766
0.5131
0.9940
0.3592
0.6379
0.7261
0.3186
0.9243
1.0000
of PSP toxins relative to the toxicity of STX (2).

The symptoms resulting from ingestion of the PSP toxins can develop
rapidly, within one hour, after ingestion. The symptoms include tingling and
numbness of the peri-oral area, followed by loss of motor control, drowsiness,
dizziness, incoherent speech, respiratory paralysis in severe cases, and in rare
cases death (12; 27). Allowable levels of PSP toxins in mussels have been
established by FDA in order to prevent these potentially hazardous outcomes
(28).
The PSP toxin level is often expressed in terms of "ug STX equivalents
per 100 grams of shellfish tissue". The term "ug STX equivalents" is defined as
the sum of the masses of all PSP toxins multiplied by their relative toxicity
factors. In New Hampshire, when PSP toxin levels in shellfish reach a level of 44
ug STX equivalents per 100 grams of shellfish tissue, the results must be
immediately reported to the microbiology section manager of the New Hampshire

Public Health Laboratories (NHPHL), the director of NHPHL and the NH shellfish
specialists for more frequent testing (27). The actionable level for PSP toxins,
which has been established by the U.S. Food and Drug Administration (FDA), is
80 ug STX equivalents per 100 grams of meat (29). When this level is reached,
the shellfish beds are closed for harvesting. The economic losses due to closure
of these fisheries include lost sales, the cost of medical treatment for patients,
and the budgets spent on additional programs for environmental monitoring (30).
1.2 Preventive Shellfish Toxin Monitoring Program in New Hampshire
To prevent PSP from affecting the public, New Hampshire has had a PSP
monitoring program for over 20 years. The program consists of sampling and
testing shellfish for the PSP toxin levels every week during the red tide season,
which is from April to October. The NH Department of Environmental Services is
responsible for collecting the shellfish and delivering the samples within 20 hours
of collection, to the microbiology laboratory of the NHPHL. Blue mussels, which
tend to accumulate toxins in their digestive glands more quickly than other
bivalves, are usually collected. The two mussel sampling sites are
Hampton/Seabrook Harbor and the Isles of Shoals. The microbiology lab
completes testing using the mouse bioassay within 24 hours after receiving the
shellfish. Data collected by the NH State Public Health Laboratories are shared
with neighboring states, including Massachusetts and Maine.
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1.3 Methods for Measuring Shellfish Toxin Levels
1.3.1 Mouse Bioassav
The Association of Official Analytical Chemists (AOAC) approved method,
mouse bioassay, which is the current accepted standard method, is employed for
weekly testing of the PSP levels in shellfish by the NHPHL (31),. The Mouse Unit
(MU) is the unit of measurement for the mouse bioassay. The MU represents the
minimum amount of poison needed to cause death in a 20-gram-mouse within 15
minutes after injecting 1-ml of shellfish extract intraperitoneally (27). Death time
is recorded for each mouse (3 mice for each analysis) to the nearest second. The
median death time must be greater than 5 minutes. If the time to death is less
than 5 minutes, the shellfish extract must be diluted and the test repeated until
the time exceeds 5 minutes. The MU, which has an inverse relationship to the
death time, is determined based on a list of pre-established values from the
Sommer's Table (32). In order to acquire consistent results, a weekly
standardization is performed using a FDA STX reference standard to obtain a
conversion factor (CF). The factor (0.22 for NHPHL) is re-checked once every
week by injecting five mice with the STX standard to ensure the results are
consistent within +/- 20%. The unit of ug STX equivalents per 100 grams of meat
is used to express the final concentration of PSP toxins in shellfish. The
concentration expressed in terms of ug STX equivalents per 100 grams of meat
is calculated using the following equation:

Median CMU/ml x CF x DF x 200
where
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CMU = corrected mouse unit ( = multiplying MU by weight correction factor)
CF = predetermined conversion factor (0.22)
DF = dilution factor
The AOAC mouse bioassay has been employed as the official method
worldwide for over 50 years. However the results of this method lack precision,
with an inherent variability in excess of +/-20% (33). This variability is relatively
high compared to instrumental methods (18; 29). Eight laboratories were tested
for proficiency using the AOAC Mouse Bioassay in an interlaboratory study. The
reported relative standard deviation (RSD) ranged from 5.4 to 9.8% for the intralaboratory analyses and from 7.8 to 39.6% for the inter-laboratory analyses (34).
The purpose of using a correctly calibrated bioassay is that the result is
considered to be more relevant to human health even though there may be
differences in the reactions between individual animals or different species. In
addition, the bioassay provides results in terms of total toxin level, though it gives
no information about the specific toxins which exist in the mussel samples (35).
Also mice with different health conditions, weight, and gender may result in
variability in time-to-death after injection, leading to uncertainty in test results
(36). A serious concern about the mouse bioassay is the large quantity of animal
waste that is generated during the period of analysis. There is also an ethical
concern in terms of animal rights. Therefore, there is sufficient reason to
investigate alternative methods for monitoring PSP toxins in shellfish.
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1.3.2 Chromatographic Techniques
Consequently many chromatographic techniques have been developed to
provide quantitation of individual toxins at very low levels. Reversed Phase High
Performance Liquid Chromatography (RP-HPLC) coupled to fluorescence
detection (FD) has become the most commonly used combination (3; 37; 38; 39;
40; 41; 42; 43; 44; 45). Since PSP toxins lack chromophores for UV absorbance
and fluorophores for fluorescence detection, pre- or post- column oxidation
procedures are used to derivatize the toxins under alkaline conditions. Early work
by Bates and Rappoport (25) showed that STX can be oxidized to produce
fluorescent derivatives. This approach provided improved sensitivity compared to
the mouse bioassay. Since PSP toxins are unstable and rapidly decompose in
alkaline medium, the analysis must be performed immediately following the
oxidation process. Therefore, routine maintenance of the derivatizing reactor and
preparation of oxidation reagents are necessary for this method. In the early
development of RP-HPLC/FD by Oshima (2), three separate chromatographic
runs using three different mobile phase gradients were performed for each
sample in order to separate all three groups of PSP toxins.
In the past decade, a HPLC/FD method from Lawrence's collaborative
study (41) was certified by AOAC. This method became the official and the
approved instrumental method for the analysis of PSP toxins in mussels after the
AOAC mouse bioassay. An interlaboratory study by Lawrence was performed to
evaluate the suitability of using this method for the determination of toxin levels in
shellfish. The study was a collaborative effort between eighteen EU laboratories.
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The results obtained by analyzing many samples of six different types of bivalve
mollusk (mussel, clam and scallop) were compared. The interlaboratory results
for all of the samples showed that the RSD ranged from 18 to 25%, which is an
improvement over the mouse bioassay (46). However it has been noted that the
HPLC/FD method requires an excessive amount of time in reagent preparation
and also multiple steps are required to derivatize the toxins (2; 45; 47; 42; 37;
48). The time required for sample preparation and analysis could be a limitation
when handling a large number of samples using this method. Another drawback
of using fluorescence detection is that individual toxin identities cannot be
confirmed by specific molecular information as opposed to a MS method that
would give information about the toxin's mass-to-charge ratio (m/z). Matching
retention time of the unknown analytes to that of the standard toxin peaks on the
chromatogram is the not considered as a physical method of identification.
As shown in Table 1.3, many researchers from different geographic
locations have established shellfish toxin profiles mainly using the LC/FD
technique along with the toxin derivatization method. Table 1.3 shows the major
toxins found in each location around the world. The results show variation in PSP
toxins present in samples and that no toxins in particular are consistently found in
all shellfish.
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Sampling Site

Method

Type of
sample

Major toxins

Bay of Fundy, Canada
Mediterrean shore,
Morocco (44)
Gulf of Paria, Trinidad, 1999
(49)

LC/FD

Alexandrium
fundyense

GTX1&4, GTX2, NEO, STX

LC/FD

Clam

LC/FD

mussel

C-toxins, B-toxins
GTX 1&4, GTX 2&3,
dcTX2&3

LC/FD

mussel

NEO, GTX2&3, dcGTX2&3

LC/FD

mussel

GTX 2&3

mussel

GTX 1-4, STX, NEO

Gulf of Paria, Trinidad, 2000
S. Atlantic coasts, Morocco
(38)
Bay ofFundy (50)
Chile (51)

LC/FD

phytoplankton

C1&2, GTX 1&4, Bl

Chile

LC/MS/MS

phytoplankton

C1&2, GTX 1&4

Danish Lakes (52)

LC/FD
LC/TOFMS

phytoplankton

STX, NEO, GTX 4

starfish

STX, NEO

Kure Bay, Japan (53)

Table 1.3. Major PSP toxins in shellfish detected in worldwide locations.
Although the inexpensive LC/FD official method was preferred for
regulatory monitoring, there is a need for spectroscopic methods to confirm the
presence of toxins of interest regarding their m/z (54). In addition, the mass
spectrometer is required for discovering new toxins and compounds present in
the shellfish on an ongoing basis. Therefore, scientists started to employ a new
combination of separation and detection method: HPLC/MS.
An innovative chromatographic approach that has been developed uses
ion-pairing agents with a reversed phase column coupled to mass spectrometry
for reducing the hydrophilicity of the solutes to achieve stronger retention (40).
Since highly polar compounds have little interaction with a nonpolar stationary
phase, the addition of an oppositely charged ion pairing agent in the mobile
phase helps to retain the analyte. The ion pairing agent may adsorb to the
stationary phase through non-polar interaction, followed by an ion exchange
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interaction between the analyte ion and the stationary phase (55; 56).
Alternatively, an analyte ion can pair with the ion pairing agents of the opposite
charge in solution, followed by a non-polar interaction between this ion pair and
the non-polar stationary phase. Therefore, the analyte is able to be retained by
the stationary phase. Unfortunately, some ion-pairing agents can cause ion
suppression of the analyte signal when interfaced with a MS detector. For
example, trifluoroacetic acid (TFA), as a strong acid, increases the conductivity of
the solution and thereby affects the stability of nebulization (57). In addition, the
RP-LC method used by Pleasance (58), has employed heptanesulfonic acid as
an ion pairing agent in the mobile phase. This acid is nonvolatile and suppresses
the MS signal when monitored in the positive ion mode (59). Ionic exchange
columns have also been used (43) for separating charged PSP toxins.
Recently, the development of an innovative method has prompted our
research efforts to use hydrophilic stationary phases to separate of toxins in
shellfish, with mass spectrometry as the detection method. Two recently
published methods by Quiliam and Diener employ a hydrophilic liquid
chromatography column (HILIC) coupled to MS/MS detection for toxin analysis
(60; 3; 61). The use of a high organic concentration in the mobile phase along
with the elimination of ion-pairing agents enhances the MS responses of the
analytes, resulting in a lower limit of detection (60; 62). Polar PSP toxins are
strongly retained on the HILIC polar stationary phase as opposed to using a nonpolar reversed phase stationary phase. The development of the new HILIC
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method provides a complete separation of three groups of PSP toxins in one
chromatographic run (3).
HILIC has been proven to be effective in separating polar compounds in
biological matrices (63). With the addition of an organic acid to the mobile phase,
more protonated molecules are formed which is an advantage for MS detection.
Since MS allows detection and identification of the polar toxins based on their
mass-to-charge ratios (64), there is no need to use a derivatization process as is
required for UV and/ or fluorescence detection.
Although LC/MS methods have improved, it is essential to have efficient
sample extraction and clean-up procedure to reduce the effects of the mussel
matrix on both the chromatographic system and the MS response. Extensive
sample extraction and clean-up procedure are required prior to the instrumental
analyses in many methods. Solid-phase extraction (SPE) and ion exchange
cartridges are often used for removal of matrix components and to separate the
PSP toxins into three distinct groups: the STX, GTXs and carbamoyl
components. (65; 58; 66). Consequently, a HILIC/ESI-MS method has been
developed and validated based on the published HILIC/MS analysis of PSP
toxins by Diener (3). The method was improved by incorporating an efficient, high
throughput clean-up procedure for routine quantitative analysis, especially to
moitor the toxins levels in ussels taken from NH coastal waters during the red
tide season.

14
1.4 Analytical Methodology for Separation and Detection of Shellfish
Toxins
1.4.1 HPLC Stationary Phase - Zwitterionic Hydrophilic Interaction
Chromatrographv (ZIC-HILIC)
Zwitterionic hydrophilic interaction chromatography (ZIC-HILIC) which is
derived from HILIC, employs a zwitterionic and polar stationary phase for
separating ionic-polar compounds. HILIC was developed because ionic-polar
compounds were found to elute close to the dead time when using reversed
phase conditions (67). The fact that ZIC-HILIC is able to retain polar compounds
can make separations more effective by providing stronger retention than when
using reversed phase conditions. The retention mechanism of ZIC-HILIC is
similar to normal phase (NP) chromatography except that NP does not generally
have ionic interactions between the stationary phase and the analytes, nor does
it use a high concentration of water-miscible organic modifier in the mobile
phase. Retention in ZIC-HILIC is achieved by two types of interactions between
the analytes and the stationary phase (68): The primary retention mechanism is
hydrophilic partitioning. Electrostatic interactions act as a secondary mechanism
for achieving retention and providing selectivity. The ZIC-HILIC stationary phase
is composed of sulfobetaine functional groups (Figure 1.2). Each sulfobetaine
group has a positively charged head group attached to the porous silica surface
and a negatively charged tail (68).
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CHo

J
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CH3
Figure. 1.2. A functional group of the zwitterionic stationary phase containing a
positive head and a negative charged tail (4).

Charged analytes can be separated selectively by interacting not only with
the polar stationary phase, but also by binding to the positively and negatively
charged (zwitterionic) functional groups, creating an ionic interaction. Both HILIC
and reversed phase chromatography use similar types of mobile phase modifiers
including acetonitrile and methanol.
Overall, ZIC-HILIC is able to capture some important properties of all three
commonly used chromatographic stationary phases. It uses water-miscible
organic eluents which are also used in reversed phase liquid chromatography
(RPLC). It is able to separate ionic compounds, which is similar to ion exchange
chromatography. It also employs a polar stationary phase for stronger retention
of polar compounds which is similar to normal phase liquid chromatography.
1.4.2 Electrosprav Ionization - Mass Spectrometry (ESI-MS)
The basic principle of mass spectrometry is that sample molecules are
ionized and then separated based on the ions' mass-to-charge ratio (m/z) (69).
An important aspect of mass spectrometry (MS) is the production of charged ions
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from neutral species. The principal components of a mass spectrometer include
an ion source, a mass analyzer, and a detector as shown in Figure 1.3 (70).
Usually a sample in liquid/gas form is introduced into the ion source of the MS
system where neutral analytes are converted to charged, gas phase, molecular
ions. These molecular ions may undergo fragmentation. All ions are separated in
the mass analyzer based upon their m/z and are detected proportionately to their
relative abundances (71).

Sample
Introduction

Ion Source

Mass
Analyzer

Detection

Figure 1.3. Diagram illustrating the four major stages of a mass spectrometry
analysis
Electrospray Ionization (ESI) is one of the MS ionization sources which
provides an interface to an HPLC. One characteristic of ESI is that it is
considered to be a "soft" ionization technique since it generates molecular ions
with little fragmentation. Another characteristic of ESI is that it operates at
atmospheric pressure, which allows ESI to be readily coupled to a HPLC (72).
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The ESI process begins with the introduction of the eluent from the HPLC
through a probe into the MS system. This eluent containing the analytes of
interest is then delivered to a capillary tube where an electrical potential is
applied. With the aid of a desolvation gas (e.g. N2), a stream containing the
sample and solvent are charged inside the tube before dispersing into a mist of
fine aerosol droplets at the tip of the ESI needle. Droplet formation occurs and
forms a "Taylor Cone", also called the "electrospray" (73; 74). Charged droplets
then evaporate and shrink into smaller sized droplets (75). Charge repulsion
overcomes the surface tension of the droplet and fragmentation occurs. The
orthogonal design (so-called Z Spray of the Waters Micromass instruments)
enhances the desolvation process by reducing the unwanted molecules that
interfere with the analysis (76).
After the ESI process, protonated and fragmented ions in the positive
mode pass through the extraction cone while evacuation occurs at low pressure
under the operation of a differential multistage pumping system comprised of a
rotary pump and a split flow turbomolecular pump (77). The rotary pump supports
the turbomolecular pump and also pumps the first vacuum stage of the source
(78). The turbomolecular pump evacuates the second vacuum stage of the
source and the analyzer region. The mass analyzer (quadrupole) is operated
under this high vacuum, sorting out singly or multiply charged ions according to
their mass-to-charge ratio (79). The most commonly used mass analyzer is the
quadrupole analyzer that consists of four cylindrical metal electrodes. These
electrodes are aligned parallel to each other in pairs. Direct and alternating
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current (DC and AC potentials) are applied to the electrodes to generate an
oscillating electric field, in which charged species are separated into ions with
specific m/z for detection (70).
Detection can be performed in either and/or both of two modes for the
same analysis: Total Ion Chromatogram (TIC) and Selected Ion Recording (SIR).
The use of TIC mode enables a wide range of masses to be collected. The
disadvantage is that it lacks sensitivity for specific m/z ions. For this reason, TIC
is used mainly for scanning for unknown compounds. Once a single m/z for a
given analyte is known, SIR can be used to enhance sensitivity in place of full
scan data acquisition (80), which allows only a specific m/z or a range of specific
m/z to travel through the quadrupole and be detected.
One of the advantages of using the combination of HILIC and ESI for this
application is that this mode of chromatography enhances MS ionization by using
higher concentration of volatile organic solvents in the mobile phase and by
effectively separating polar analytes during separation prior to entering the MS
nebulizer (81).
1.5 System Suitability Test
Prior to acquiring data for any sample, it is important that the analytical
instrument be properly equipped, calibrated and qualified for the analysis (82). A
system suitability test must be performed to show that the instruments are
operating properly and that they are capable of producing reliable data.
Generally, consistency of system performance and chromatographic suitability
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are the main components of system suitability. The criteria for evaluation should
include defining appropriate system suitability criteria such as capacity factor,
repeatability, resolution, tailing factor, injection precision and the number of
theoretical plates produced (83; 84). The capacity factor (k') defines the time an
analyte interacts with the stationary phase relative to the time it spends in the
mobile phase where: k' = (tR - to)/10, tR is the retention time of an analyte and to is
the void time (85). When the k' is too small, the analyte has little interaction with
the stationary phase and thus elutes too early. For this reason, k' should be no
less than 2 for any of the analytes. Repeatability is a series of repetitive
measurements taken by an instrument for samples prepared using the same
procedure. Resolution (R) is a measurement of how well two analytes, 1 and 2,
are separated. R = (tR2 - tR2)/[0.5 (WBi + WB2)] (86), where tR is the retention time
and WB is the width at baseline of the band of each analyte. The tailing factor is a
measure of peak tailing. It is defined by the width of the peak at 5% peak height
divided by two times the front half width of the peak at 5% of the peak's height: T
= W5%/ 2 W-i/2. The number of theoretical plates (N) is a measure of band
spreading of the analyte's peak. The equation, N = 16 (tR /WB)2, is used to
calculate the number of theoretical plates. A greater number of theoretical plates
is indicative of a more efficient chromatographic column (87).
The parameter limits given in Table 1.4 are recommended by and
summarized from the guidelines of the US Food and Drug Administration (FDA)
(88), US Pharmacopeia (USP) (89) and the International Conference on
Harmonization (ICH) (90):

Parameters

Suggested Limits

Capacity factor (k')

k'> 2.0

Repeatability

RSD<1%forN>5

Relative retention

Not essential as long as Resolution is stated

Resolution (R)

R>2

Tailing factor (T)

Tof<2

Theoretical plates (N)

>2000

Table 1.4. System suitabilil y parameters and suggesjted limits summarized frc
the FDA, ICH and US Pharmacopeia.
These recommendations were used as a reference to set suitable
parameters and limits. Over the process of method development, values of these
parameters can be adjusted depending on the instruments, materials available,
samples to be analyzed and experience with the method. An important element
used throughout the analysis is a quality control sample, which is used to monitor
the instrument's performance within a batch of samples (91).
1.6 Method Validation Process
Method validation is a series of tests conducted to ensure the results
produced by the instrumental method and sample preparation procedures are
reliable and reproducible for its intended use (92; 93). If a biological sample is to
be analyzed, different approaches may be taken regarding the type of tests
employed, depending on the nature of the sample matrix and also the analytes of
interest. For this reason, validation tests are customized for the specific method
being used or developed. Several method validation documents were reviewed
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when developing this method including the guidelines provided by the ICH (94),
FDA (95) and Food Emergency Response Network (FERN, which is coordinated
by Department of Health and Human Services/FDA and Department of
Agriculture/ Food Safety and Inspection Service), and the in-house procedures
used by the NH PHL. To establish a valid method, the following characteristics of
the analytical procedures were determined over a period of time and provided
useful information for the validation process.
Accuracy
•

Precision

•

Recovery

•

Linearity

•

Limit of Detection (LOD)

•

Limit of Quantitation (LOQ)

•

Robustness

•

Stability of analytes and biological samples
The main objective of this study was to develop a LC/MS method for

separation and detection of toxins in mussels from NH waters. The method
developed employs a more effective and efficient clean-up method for the routine
analysis of PSP toxin levels of mussels. The second objective of this study was
to evaluate the specific PSP toxin profiles in mussels from two collection sites in
NH during the period from April to October, 2009. The overall toxicity levels as
measured by the LC/MS method were compared to the results provided by the
bioassay.
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CHAPTER 2

MATERIALS AND METHODS

2.1 Instrumentation
The LC system that was employed for this analysis was a Waters 2695
Alliance low-pressure mixing quaternary gradient HPLC system (Milford, MA),
with in-line vacuum degassing. The autosampler had a maximum capacity of 120
vials with programmable temperature control over the range of 4°C to 40°C. A
heated column compartment provided temperatures from 5°C above ambient to
65°C. The injection valve allowed injection volumes ranging from one to a few
hundred microliters. The MS system to which the chromatograph was interfaced
was a Micromass ZQ Mass Spectrometer (Milford, MA). Chromatograpms and
mass spectral data were displayed and analyzed using MassLynx software 4.1.
The chromatographic system consisted of a 2 urn prefilter (Upchurch Scientific,
Oak Harbor, WA) in line with a ZIC®-HILIC PEEK guard column (2.1mm x
20mm, 5 urn), followed by a ZIC®-HILIC analytical column (2.1 x 150mm PEEK,
3.5 urn, 200A) (SeQuant AB, Umea, Sweden).

2.2 Materials
2.2.1 Solvents
Purified water (resistance of 18 M ohm) was obtained from a Millipore
Milli-Q Gradient A-10 water source (Bedford, MA). Formic acid (99% w/w) was
purchased from Acros (Fairlawn, NJ). Both acetonitrile (Optima LC/MS grade)
and ammonium formate (100%, Certified Crystalline) were obtained from Fisher
Scientific (Fairlawn, NJ).
2.2.2 PSP Toxin Standards
The solvents used for preparing the toxin standard solutions, including
glacial acetic acid (HPLC grade) and hydrochloric acid (ACS reagent grade,
36.5-38% w/w) were purchased from Fisher Scientific (Farlawn, NJ) and MP
Biomedicals (Solon, OH) respectively. Toxin Standards were obtained from the
National Research Council (NRC) (Halifax, Canada) in 0.5-ml ampoules and
were used for LC/MS analysis in this project: saxitoxin (STX), neo-saxitoxin
(NEO), decarbamoyl-saxitoxin (dc-STX), carbamoyl-gonyautoxin-1 & -4 (GTX-1
& -4) and carbamoyl-gonyautoxin-2 & -3 (GTX-2 & -3). The 1 ppm STX reference
standards prepared by the mouse bioassay lab were originally obtained from the
Food and Drug Administration (FDA, Washington, D.C.) and used for mouse
bioassay testing.
2.2.3 Mussel Sampling
Blue mussels (bivalves) were collected weekly from two locations on the
New Hampshire coastline from April to October 2009. The New Hampshire

sampling sites were Hampton Harbor and the Isles of Shoals. Personnel from the
Department of Environmental Services delivered the samples to the microbiology
lab of NHPHL within 20 hours of collection. Toxin analysis using the mouse
bioassay must be carried out within 24 hours after arrival. Mussel extracts
prepared by the microbiology lab for bioassay were sent to the Chemistry lab at
NHPHL for LC/MS analysis.
2.2.4 Sample Clean-up Devices
The first stage of the cleanup procedure involved centrifugation using a
MiniSpin Plus centrifuge, which is capable of spinning to a maximum speed of
14,500 rpm and accommodates up to twelve 2-ml safelock snap cap
microcentrifuge tubes which are made of polypropylene. Both the centrifuge and
microcentrifuge tubes were manufactured by Eppendorf (Oldenberg, Germany).
Syringe filtration was then performed using an Acrodisc 13 mm syringe filterdisc
with a 0.2 urn GHP (hydrophilic polypropylene) membrane (HPLC certified)
manufactured by PALL (Ann Arbor, Ml) equipped with a 1-ml disposable slip tip
syringe obtained from BD (Franklin Lakes, NJ). A centrifugal filter device was
used for processing the mussel extract after syringe filtration. This was the last
step of the clean-up procedure to be completed prior to injection into the HPLC.
Two versions of the centrifugal filter devices purchased were both manufactured
by Millipore (Bedford, MA). Microcon devices were used for most of the
quantitative analyses which established the toxin profiles for the 2009 season.
The Microcon devices were replaced with an improved version- Amicon, for
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analyses performed after mid-September. Because Millipore discontinued
manufacturing the Microcon devices and they were no longer available for
purchase, it was decided to use the improved Amicon devices for the rest of the
quantitative analyses. The Amicon devices were used for samples analyzed after
mid-September 2009, both the Microcon and Amicon devices are equipped with
a filter unit and a centrifugal tube. Both types of devices have a filter unit made of
the same material- ultracel regenerated cellulose. The nominal molecular weight
limit for both devices is 3000 Daltons, indicating that only molecules smaller than
3000 Daltons can pass through. The main difference between the Microcon and
Amicon devices is the orientation of the membrane in the devices.
2.3 Methods
2.3.1 Preparation of Mobile Phases
Mobile phase A consisted of water. Mobile phase B consisted of 15 mM
ammonium formate and 15 mM formic acid buffer adjusted to a pH of 3.8 using
HCI. Mobile phase C was acetonitrile. The aqueous mobile phases were filtered
using 0.45 urn filter paper prior to use.
2.3.2 Preparation of PSP Toxin Standards
A solution containing 0.003 M HCI and 0.01 M acetic acid was used for
preparing stock solutions of all four GTX toxin standards. 0.003 M HCI was used
to prepare the STX, NEO and dc-STX standards. All toxin solutions were stored
below -20°C. All PSP toxin standards were received in 0.5 ml ampoules and were
further diluted to the stock concentrations individually as given in Table 2.1. To

prepare the toxin mixtures, stock solutions were combined and diluted in two
groups: 1) STX, NEO, and dcSTX; 2) GTX-1, -2, -3 and -4.
PSP Toxins

Concentration of toxins in
ampoule (ppm)

Stock Concentration
(ppm)

STX

24

3.0

NEO

25

3.2

dcSTX

20.4

2.55

GTX 1 and 4

27.1,8.82

3.38, 1.10

GTX 2 and 3

46.7, 15

5.83, 1.9

Table 2.1. Concentrations of PSP toxin standards as received and in stock
solutions in ppm (conversion of concentration unit, uM, given on the certificate of
analysis for each PSP toxin, to ppm (=ug/ ml).

2.3.3 Mussel Extraction
The mussel extraction process was performed by the personnel of the
microbiology lab for use with the mouse bioassay and for our instrumental
analysis. Between 20-25 tightly closed and undamaged mussels were chosen.
Debris and barnacles on the shell surface were cleaned off with a scrub brush.
The shells were opened by placing a shucking knife towards the hinged side of
the mussel, while avoiding cutting into the meat (Figure 2.1)

Hinged side towards
towards shucking knife

Figure 2.1. Proper way of opening a mussel.

The entire insides of the mussels were scraped into a sieve. The shucked
mussel meat was drained for five minutes and homogenized in a blender at high
speed for approximately 2 minutes until homogeneous. Into a tared beaker, 100
grams of homogenate were weighed and mixed with an equal mass of 0.18 M
HCI. At this stage, the mass of the mixture was recorded. The mixture was then
heated to 100°C for five minutes with an evaporating dish placed over the
beaker. Due to the loss of water during the boiling process, a sufficient volume of
0.003 M HCI was added to bring the total weight of the mixture to its original
mass. The mixture was centrifuged for five minutes at 3000 rpm. The
supernatant was removed and stored at 4°C or analyzed using the mouse
bioassay. A portion of the supernatant was sent to the Chemistry lab for sample
clean-up followed by LC/MS analysis or was stored in a freezer below -20°C until
analysis.
2.3.4 Sample Clean-up Method
The procedure for sample clean-up using either a Microcon or Amicon
device (both manuafactured by Millipore) is very similar except that the overall
spinning time for the Microcon device is approximately 160 minutes longer than
for the Amicon device (see Appendix for the detailed clean-up procedure). This
procedure is applied for both toxin screening and quantitative analyses. The
ultrafiltration membranes in the Amicon and Microcon filter unit contain trace
amounts of glycerine that must be removed prior to use. Each unit was rinsed by
loading 0.5 ml of 0.003 M HCI into the filter unit, which was then inserted into a
microcentrifuge tube. Both the Amicon tube and the unit were spun at 14,500

rpm for 30 minutes (100 minutes for Microcon). To remove the solvent remaining
inside the unit, the filter unit was placed upside down into the same centrifuge
tube and centrifuged for another 15 minutes (60 minutes for Microcon). The tube
containing the rinsate was discarded and replaced with a new one. (Figure 2.2)
Rinsed
filter
unit

New tube

Figure 2.2. Two components of an Amicon device including the pre-rinsed filter
unit and tube for filtrate collection (5).
A 0.1 ml aliquot of the mussel extract received from the Microbiology lab
(where the mouse bioassay is conducted), was diluted to 1 ml with 0.003M HCI
resulting in a dilution factor of 10. (Note: If the LC/MS screening results shows a
relatively high toxin level in the extract, additional dilutions were required prior to
centrifugation to proceed to quantitative analysis). Into a 2-ml regular centrifuge
tube, 0.5 ml of the diluted extract was loaded. The tube was centrifuged for 15
minutes (100 minutes for Microcon) at 14,500 rpm. The supernatant (about 600
ul) was removed and filtered through a 0.2 urn GHP membrane disc (HPLC
certified) equipped with a syringe, into a pre-rinsed Amicon/Microcon device (with
tube) prepared as described above. The Amicon device loaded with supernatant
was placed in the centrifuge and spun for 15 minutes at 14,500 rpm. Filtered
extract was collected in the bottom tube from the Amicon/Microcon device. The

29
extract was then used for screening or quantitative analysis by LC/MS. If the
toxin peak in the cleaned-up extract is detected by LC/MS with a S/N larger than
5, a second batch of the same mussel extract is required to be processed
through the clean-up procedure to prepare a sample set for quantitative analysis.
If no toxin peaks or only a trace amount of toxin (S/N < 5) is detected, no
quantitative analysis will be performed on this sample. It should be noted that the
mussel extract is only diluted to 1:20 when being screened including the 1:1
dilution from Microbiology lab and 1:10 dilution prior to the clean-up procedure.
The sample will be diluted to 1:40 when it is spiked with toxin standard (1:1) for
quantitative analysis. A S/N=3 is estimated to be the LOD and a S/N=10 is
estimated to be the LOQ. If the toxin peak is screened and has a S/N=5, then the
response is larger than the LOD but less than the LOQ. Since this S/N level was
obtained for a dilution factor of 1:20, it is possible that a slightly larger response,
possibly a S/N>10, will be observed, when the sample is diluted to 1:40 due to
the effect of diluting matrix has on the MS responses of toxins (see section 4.4.2
for dilution of matrix studies). Therefore, a S/N> 5 was set as the requirement for
proceeding on to quantitative analysis of the toxins in the mussels.
2.3.5 Instrumental Method
HPLC Parameters:
Key parameters such as the mobile phase gradient profile, mobile phase
flow rate and column temperature were evaluated to improve resolution, retention
time, sensitivity and peak shape. Buffer concentration was adjusted to optimize

the intensity and shape of the peaks. Flow rates from 0.15 ml/min to 0.3 ml/min
and column temperatures from 30°C to 60°C were evaluated. The following
conditions were finalized and are recommended for routine operation: The flow
rate of 0.2 ml/min provides optimal MS detection for a 2.1mm x 200mm column.
The column temperature was set at 30°C and the autosampler temperature was
set at 15°C. A sample injection volume of 5 pi was used. Mobile phase A was
water. Mobile phase B is 15 mM ammonium formate/15 mM formic acid. Mobile
phase C is acetonitrile. The mobile phase gradient profile is given in Table 2.2.
After all of the toxins eluted, the mobile phase conditions were adjusted back to
the intial conditions.
Time (min)

A (%)

B (%)

C (%)

0.00

18.0

18.0

64.0

5.00

18.0

30.0

52.0

10.00

2.0

50.0

48.0

20.00

2.0

50.0

48.0

20.10

18.0

18.0

64.0

30.00

18.0

18.0

64.0

Table 2.2. Gradient elution method: a 30 minute gradient run at a flow rate of 0.2
ml/min (a modified version of the gradient method used by Diener) (3)).
MS Parameters:
The analyses for all of the PSP toxins were performed in the positive ion
mode. Selected Ion Recording (SIR) spectra were collected for 10 m/z of the
PSP toxins, which included the quantifier ions and fragment ions shown in Table
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2.3. The MS responses were obtained from the abundant protonated (M+H)+ ions
of STX (m/z=300.1) and its analogs, NEO (m/z= 316.10), dcSTX (m/z= 257.20),
GTX 3(m/z= 396.20) and GTX 4 (m/z= 412.5). Due to the loss of S0 3 , m/z=
322.00 and m/z= 316.20 were the abundant ions used for monitoring GTX 1 and
GTX 2 and for quantification. The fragment ions shown in Table 2.3 were used to
verify the presence of the PSP toxins in addition to the quantifier ions. The
electrospray source was operated with a nitrogen desolvation gas flow rate of
650 L/hr to aid in solvent evaporation and to prevent damage to the source. The
entire eluent from the HPLC column was directly transferred to the electrospray
source. Tuning is a process including adjusting source settings, analyzer
settings, and gas flows to produce optimal peak intensities specifically for the
ions being analyzed, followed by tuning to accommodate all the toxins as one
final setting. Tuning was done by injecting each toxin standard into the MS probe
directly and by injecting directly into the MS probe with the initial mobile phase
flow from the LC while monitoring the signal of the toxin at its m/z.
Toxins
STX
NEO
dcSTX
GTX1
GTX 2
GTX 3
GTX 4

Quantifier Ion
300.10
316.10
257.20
332.00
316.10
396.10
412.50

Fragment Ion
282.10
298.10
239.20
412.5,298.10
396.10
298.10
298.10

Table 2.3. Quantifier and fragment ions of toxins detected by ESI-MS. Quantifier
ions are used for quantification for each toxin in selected ion recording (SIR)
mode.

In order to optimize the MS conditions, tuning several parameters for both
the formation and detection of ions was necessary. The final settings for the MS
parameters tuned are presented in Table 2.4. The source and desolvation
temperature settings control desolvation at the specified flow rate of 0.2 ml/min.
The voltage parameters shown in Table 2.4 were optimized for sensitivity and
stability. The desolvation gas flow was optimized based on the mobile phase
composition and the flow rate. The LM (low mass) 1 and 2 resolution were
adjusted to optimize the peak intensity, and resolution by altering the sensitivity
of the MS detector.
SOURCE (ES+)

SETTINGS

Capillary (kV)

3.11

Cone (V)

30.00

Extractor (V)

3.00

RF Lens (V)

0.1

Source Temperature (°C)

130

Desolvation Temperature (°C)

450

Cone Gas Flow (L/Hr)

0

Desolvation Gas Flow (L/Hr)

650

ANALYZER

SETTINGS

LM 1 Resolution

8.1

LM 2 Resolution

16.2

Ion Energy

0.5

Multiplier

874

Table 2.4. Electrospray-mass spectrome ter (ESI-MS) tuning parameters.
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Another set of parameters was also tuned which involved adjusting the ion mode
and the ion scanning rate during the analysis (Table 2.5). Scan time represents
the frequency of scanning for a specific mass. The interscan time allows a small
break in time between scan times.
Type

SIR

Ion Mode

ES+

Data Format

Centroid

Scan Time (sec)

0.50

InterScan Time (sec)

0.10

Span (Da)

0.60

Start Time (min)

0.0

End Time (min)

30.0

Cone Voltage (V)

80.0

Table 2.5. Electrospray-mass Spectrometer (ESI-MS) ion-scanning parameters
at ES+ mode
Ten masses were entered as SIR channels to be monitored in a single
scan function. The cone voltage for each mass was optimized. The higher the
voltage applied to that specific species, the greater the fragmentation induced.
The cone voltage was tuned at each mass to produce the highest intensity for the
specific toxin (Table 2.6).
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Ch
Mass (Da)
Dwell (s)
Cone (V)
Delay (s)
1
239.20
0.100
29.00
0.020
2
257.20
0.100
29.00
0.020
3
282.10
0.100
30.00
0.020
298.10
0.100
0.020
32.00
4
5
300.10
0.100
0.020
30.00
312.00
0.100
0.020
6
35.00
7
316.10
0.100
32.00
0.020
8
332.0
0.100
26.00
0.020
396.10
9
0.100
13.00
0.020
412.50
0.020
10
0.100
26.00
Table 2.6. MS Selected Ion Recording (SIR) method (monitored for 10 masses of
quanitifier and fragment ions of the PSP toxins from 0.00 to 30.00 min in ES+
mode).
2.3.6 Sample Set Preparation
To perform a quantitative analysis for the PSP toxins in a single mussel
extract sample, a sample set of 8 vials were prepared as shown in Table 2.7. The
preparation procedure for each vial is given in this table. The required time for
the LC/MS instrument to analyze each vial was 30 minutes, or approximately 4
hours for the entire set.

Vial
Description
Add 100 ul of the stock, cleaned-up extract
from the last step of the "Clean-up
procedures" (additional dilution may be
necessary depending on the concentration
of the toxins) to 100 ul of 0.003M HCI
solvent
1
Mussel extract
Spike solvent with toxin standard mixture
(concentration of toxins at approximately
2
Quality control
the LOQ level)
3
Solvent Blank
Solvent: HCI (-0.003M)
4
Mussel extract
Same as Vial 1
Add 100 ul of the stock cleaned-up extract
Mussel extract (low
to 100 ul of a lower concentration of toxin
toxins, spiked after
mixture (the toxin concentration must be
5
clean-up procedures)
equal to or above LOQ)
Mussel extract (high
Add 100 ul of the stock cleaned-up extract
toxins, spiked after
to 100 ul of a higher concentration of the
6
clean-up procedures)
toxin mixture
Add 200 ul of the uncleaned mussel extract
(the same dilution as the stock cleaned-up
extract added to vials 4-6) into 200 ul of the
higher concentration toxin mixture (the
Mussel extract (high
same concentration added to vial 6). Carry
toxins, spiked after
mixture through the "Clean-up procedures".
clean-up procedures)
Refer to Figure 2.10.
7
8
Quality control
Same as Vial 2
Table 2.7. Description of sample set preparation for a total of eight vials
associated with analysis of a single mussel extract sample.
#

Sample Name

2.3.7 Data Analysis
The sample set was established to ensure the data produced are
acceptable for quantification. Four aspects needed to be considered: toxin carryover, system stability, percent recovery and linearity of the standard addition
curve (correlation factor). Each aspect is required to meet an acceptable criterion
by evaluating the results from the vials specified in Figure 2.3. It is important to

check if any toxins are carried over from run to run, which would result in an
increased response in the next run in turn producing an error in quantitation. To
ensure the system produces consistent responses, the analyte's responses were
compared at the beginning and at the end of the sample set (vial 2 and 8). The
percent error (%) should be within +/- 20%. Moreover, the percent recovery
should be in the range of 80% to 120% for all toxins quantitated in food samples.
The 3-point standard addition plot generated from the toxin responses using vials
4 to 6 is used for calculating the concentration of toxins in the mussel extract
(using simple linear correlation: y= mx + b) if all of the above outcomes meet the
criteria for quantification. Also, the correlation factor (r2) for the standard addition
curve must be no less than 0.995.

Sample Set
System Stability
Check

Carry-Over Check

No.

Description

Vial

01

Mussel Extract

3

02

Quality Control (Toxin Standard)

1

03

Solvent Blank

2

04

Mussel Extract

3

05

Spiked Mussel Extract (low toxins, Spiked
after clean-up procedures)

4

06

Spiked Mussel Extract (high toxins , Spiked
after clean-up procedures)

5

07

Spiked Mussel Extract (high toxins,, Spiked
before clean-up procedures)

6

08

Quality Control (Toxin Standard)

1

Standard Addition Plot

% Recovery of Toxins

Figure 2.3. Description of all vials in a sample set for quantitative analysis of PSP
toxins in a mussel sample.

CHAPTER 3
EXPERIMENTAL

3.1 Early Studies
3.1.1 STX Standards
The US Food and Drug Administration saxitoxin reference standard (FDA
STX) was used for standardization for the mouse bioassay. For the LC/MS
method, a certified saxitoxin standard from the National Research Council (NRC
STX) was employed for the qualitative and quantitative analyses. A comparative
study of STX standards was performed by analyzing the toxin responses for the
FDA STX and the NRC STX. Both standards were prepared to the following
dilutions: NRC STX standard was diluted to a 7.5 ppb concentration whereas it
was 50 ppb for FDA STX. Duplicate injections were made for each STX solution.
Impurities including other PSP toxins which may be present in the STX
standards, were also evaluated.
3.1.2 PSP Standards
Each of the 7 toxin standard solutions was prepared by diluting to !4 of
their stock solution concentration with the corresponding solvents mentioned in
section 2.3.2. However, STX was the only exception which was diluted to 1/6 of
its stock concentration (Table 2.1). The individual diluted toxin standards were

injected separately to determine their retention time with detection performed at
the appropriate m/z ratio for each toxin.
3.1.3. Evaluation of Matrix Effect
As mentioned previously, the effect of matrix on the analysis is an
important consideration for detection of analytes in biological matrices.
Experiments were conducted to investigate how analyte signals are affected by
the mussel matrix. Mussel #08-29 was found by the mouse bioassay to contain a
high PSP toxin level. The MS signal for STX in the mussel extract and in a 1:1
dilution of this extract prepared in 0.003 M HCI were compared with a pure STX
standard. No centrifugal filter device (Microcon or Amicon) was used for sample
clean-up at this point of the method development process.
Based on the results obtained from the above experiment, further
investigations were undertaken to examine how diluting the mussel extract
affects the MS responses for the toxins. Mussel extract #09-01 was used as a
mussel blank since no PSP toxins were found to be present in this extract by a
previous LC/MS analysis. Equal volumes of a series of the dilutions of the mussel
blank were prepared as follows: 1:20, 1:60, 1:120, 1:600, 1:1800 and a control
solvent. The 0.003 M HCI solvent was used as a control containing no mussel
matrix. Equal aliquots of standard solutions containing 7.5 ppb STX and 8.0 ppb
NEO were spiked into equal volume of each diluted mussel blank and the control
vial as well. Toxin responses from each vial were then evaluated by LC/MS.
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3.2 System Suitability
System suitability tests were developed to prove that the chromatographic
and mass spectrometric systems were suitable for the intended application.
Different approaches were taken in order to set suitable limits specifically for this
application. System suitability was tested to confirm data integrity before
proceeding with sample analyses.
The delay time of the HPLC system is the time taken between when the
computer system commands a mobile phase composition to begin and the time
taken for that mobile phase composition to reach the column. The corresponding
delay volume for this instrument is calculated by multiplying the delay time by
mobile phase flow rate. Once determined, the delay volume for this instrument is
a constant, assuming no physical changes are made to the instrument. Knowing
the delay volume, allows for a better understanding of the effect of changing
gradient elution conditions and profiles. A reversed phase column, (XTerra Ci 8 ,
2.1 x 50 mm, 3.5 urn, Waters Corp., Milford, MA), was used to measure the delay
time. Acetone was assumed to be unretained under the totally aqueous condition
in the reversed phase column and was employed to estimate the tm, the time of
elution for an unretained compound.
The gradient elution profile used for this experiment had three segments.
During the first segment, the percentage of acetonitrile increased from 0 to 100%
over 10 minutes. This was followed by holding at 100% acetonitrile for 10
minutes before returning to the original concentrations. The gradient profile is
given in Table 3.1 for the measurement of the delay volume. A 5 ul injection of
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acetone was made at time= 0. The m/z of acetonitrile (59) and acetone (42) were
monitored by the MS instrument using selected ion recording mode (SIR).
Time

% H20

% Acetonitrile

Flow rate (ml/min)

0.00

100

0

0.2

10.00

0

100

0.2

20.00

0

100

0.2

25.00

100

0

0.2

Table 3.1 HPLC elution gradient profile from 0 to 25 min used for measuring the
delay volume of the system.
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Figure 3.1. Schematic diagram showing the anticipated change in organic
composition over the gradient time.
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3.3 Method Validation
3.3.1 Percent Recovery
To ensure that the toxins of interest were not lost during the mussel
sample clean-up process (see 2.3.4), percent recovery tests for the most
commonly found PSP toxins, STX and NEO, were performed over different
mussel samples. Sixteen samples of mussel extract collected at different dates,
from the different sample sites, were used for this analysis. These samples were
provided by the microbiology lab (where mouse bioassay testing is conducted)
during the summer of 2009. To measure the percent recovery, a portion of the
mussel sample was spiked with standard toxin solutions containing STX and
NEO (30 and 32 ppb) prior to and after performing the clean-up procedure
(Figure 3.2). The percent recovery is calculated based on the difference between
the toxin responses of two samples, spiked after sample (1a) and spiked before
clean-up sample (2a) shown in figure 3.2.

1. No Spike
Diluted
mussel
extract

CLEAN-UP
PROCEDURES USING
MICROCON/AMICON

l a . Extract 1 spiked w /
toxin AFTER clean-up

2.Spike w/Toxin
2a. Extract 2 spiked w /
toxin BEFORE clean-up

% Recovery for each toxin= (Toxin signal in 2a / Toxin signal in la) x 100%

Figure 3.2. Diagram of the experimental method used to measure the recovery of
toxins in mussel extract throughout the clean-up procedure.

3.3.2 Precision
Eight injections of spiked mussel matrix containing all 7 toxins were run to
test the ability of the LC/MS to produce reproducible results. Mussel extract,
which had been found to contain none of the PSP toxins of interest, was diluted
to 1:20 with 0.003 M HCI solution and then spiked with two groups of standard
toxin solutions separately: 1) STX, NEO and dcSTX 2) GTX-1, -2, -3 and -4.
3.3.3 Estimated Limits of Detection and Quantitation
The estimated limit of detection (LOD) and limit of quanititation (LOQ) for
each toxin in the mussel matrix were established using mussel samples received
on different dates and from two different collection sites. Several extracts which
did not contain toxins were selected for determination of the LOD and LOQ. Each
extract was diluted 1:20 with 0.003 M HCI solution and was spiked with two
groups of toxin standard mixtures respectively at five concentrations: 1) STX,
NEO and dcSTX; 2) GTX-1, -2, -3 and -4. Additional dilutions of the toxin mixture
were made until the LOQ of the peak of the diluted sample reached a signal-tonoise ratio of 10. To determine the LOD, the S/N of each toxin peak must be
equal to ~3. It is expected that the LOD and LOQ for each toxin will differ in the
mussel matrix.
3.3.4. Linearity
Seven PSP toxin standards were prepared at five different concentrations
(in the unit of ppb, also ng/ ml) in two groups of toxin mixtures: 1) STX, NEO and
dcSTX, at concentrations ranging from 4.4 to 106 ppb; 2) GTX-1 to -4, at

concentrations ranging from 34.6 to 2920 ppb. The concentration ranges were
set above the LOD for each of the toxins. To ensure linearity is not limited to
toxins in aqueous solution, experiments were repeated by adding various
concentrations of toxins in mussel extracts. Each concentration was spiked into
equal aliquots of the diluted mussel extracts (1:40, without toxins) to generate a
calibration curve for each of the toxins in mussel matrices.
3.4. Stability Studies
3.4.1. Evaluation of Toxin Stability of Mussel Extract in the LC Autosampler
Mussel sample #09-13 was used to evaluate the stability of toxins in a
cleaned-up mussel sample (known to contain toxins) in the autosampler at 15°C
over a 32 hour period. The sample set method was applied to this experiment
with the same set being run eight times within a 32 hour period.
3.4.2. Evaluation of Long Term Stability of the Mussel Extract
A mussel sample, #09-13, received from the bioassay lab was distributed
into 10 aliquots in 1.5-ml-vials. All sample vials were stored in a freezer at -29 °C
starting on May 26, 2009 although the stability analysis was performed from July
through September 2009. One vial at a time was taken out of the freezer for
analysis. The contents of the vial was thawed, and processed through the cleanup procedures. The sample set was prepared according to the sample set
method for six vials on six different days between July and September.

3.4.3. Evaluation of Toxin Degradation in Standards
Two sets of STX and NEO standards were obtained from NRC of Canada,
one in September 2008 and the other in September 2009. The certificates of
analysis indicated both the 2008 and the 2009 STX standards contained 65 pM
STX, the same concentration (65 pM) for the 2008 and the 2009 NEO standards.
The old and new sets of original standards were diluted to 15 ppb STX
and 16 ppb NEO with 0.003 M HCI solution. Responses of the toxin peaks from
both old and new standards were compared.
3.4.4. Investigation of Toxin Degradation during the Sample Preparation
Process
Commercial blue mussels were purchased from a local market in
Concord, NH (raised in Canada). Fifteen tightly closed mussels were chosen and
prepared, following the mussel extraction procedures (see 2.3.3), up to the
blending process. The mussel homogenate generated was distributed into two
portions: 1) 1.5 grams of homogenate mixed with an equal amount of water and
2) 5 grams of homogenate mixed with an equal amount of 0.18N HCI. From each
portion, 0.5 grams of the diluted homogenate mixture was distributed into 1.5-ml
vials and later 0.5 grams of toxin standard mixture solutions were spiked into
each vial. The vials containing the homogenate diluted with acid were heated to
boiling for 0, 5, 10 and 30 minutes to evaluate if the toxins degraded overtime.
The vials containing the homogenate diluted with water were boiled for 0 and 10
minutes only. This experiment was originally conducted in July of 2009. A similar

experiment was performed in December 2009 for confirmation. STX and NEO
were adjusted to a higher concentration for the December experiment.
3.5 Cross-Validation Studies of Amicon and Microcon
Microcon and Amicon devices are the disposable centrifugal filter devices
which were used to clean up mussel extracts. Microcon tubes were used for
processing most of the mussel samples during the summer of 2009. Millipore
later improved the centrifugal filter technology and began manufacturing a
replacement for the Microcon tubes under the name of Amicon. The Microcon
tubes were discontinued and they were no longer available for purchase.
Although both devices contained the same filter membrane material, the
membranes are placed differently in the filter unit. In the Microcon device, the
solution filters through the membrane located on the bottom of the device directly
into the collecting tube similar to a gravitational filtering system. For an Amicon
tube, the membrane was designed to be on the vertical sides of the filter unit.
The change in orientation of the membrane may affect the results
obtained for the mussel analysis. To evaluate if the results obtained are similar
using either devices for the clean-up procedure, a cross-validation assessment
was carried out. A mussel extract, which was known not to contain toxins, was
chosen for this experiment. The extract was divided into two large batches, one
was spiked prior to and the other was spiked after the sample clean-up process
with the two groups of toxins: (1) STX, NEO and dcSTX; (2) GTX-1, -2, -3 and -4.
Each of the spiked batches was further distributed in triplicate into the Amicon
and Microcon filter devices respectively. There were a total of 12 Amicon and 12
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Microcon tubes used for this study. It should be noted that this experiment could
only be repeated a limited number of times due to the limited number of Microcon
tubes available.
3.6 Qualitative and Quantitative Analyses of PSP Toxins in Mussels
During the summer of 2009, mussel extract from two sampling sites were
received weekly from the bioassay lab. A screening process described below
was carried out for each sample to determine the approximate level of PSP
toxins. When each mussel extract was first received from the bioassay lab, it was
immediately processed through the clean-up procedures for screening. The
"clean" extract was then diluted by a factor of 1:10 and analyzed by LC/MS. If the
S/N ratio of the PSP toxin peak was found to be higher than 5, quantitative
analysis using the sample set method was conducted. If the S/N was lower than
5, no further analysis was performed. A S/N of 5 was chosen for screening
because the mussel extract will be diluted by an additional factor of 2 when
proceeding to the quantitative analysis procedure. The possibility is that the S/N
may be larger or equal to10 for the toxin peak after the dilution for quantitative
analysis due to a reduction in the effect of mussel matrix on the toxin signal.
Thus, the S/N for screening was chosen somewhere between the S/N of the LOD
and the S/N of the LOQ, which resulted in S/N= 5.
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CHAPTER 4

RESULTS AND DISCUSSION

4.1 Early Studies of Toxins
4.1.1 STX Standards
The toxin content of STX standards obtained from FDA and NRC were
evaluated with respect to retention time and m/z. The STX standards from both
providers were injected and analyzed by LC/MS. The SIR chromatograms
monitored at m/z= 300.1 for STX, m/z= 316.1 for NEO, and m/z= 257.2 for
dcSTX were generated for the STX standards from FDA (Figure 4.1) and from
NRC (Figure 4.2) respectively. Results indicated that the STX standards from
both providers contained trace amounts of dcSTX while the NRC sample
contained NEO toxin as well. It is noted that for the SIR chromatogram of the
NRC STX standard monitored at m/z= 316.1 for the presence of NEO, two peaks
eluted, one at 15.94 min, as the major NEO peak and the other smaller peak at
17.45 min (Figure 4.2). The smaller peak only appeared as an impurity in the
NRC STX standards, not in the NRC NEO standard. Therefore, only the major
NEO peak at 15.94 is quantitated and the result is not affected using the NRC
NEO standards.
Although the trace amounts of dcSTX and NEO are considered as
impurities in STX standard solution, quantitation of NEO and dcSTX in mussels is
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not affected when three toxin standards are mixed together. This is because the
concentration of the STX, NEO and dcSTX standard mixture used for quantitative
analysis is very low (3 - 34 ppb). The trace amounts of NEO and dcSTX carried
from the STX standard become proportionally lower, which are not detectable
(below their LODs).
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Figure 4.1. Chromatograms of the FDA STX standards prepared by the NHPHL microbiology lab for
standardization of the mouse bioassay monitored at three masses: (A) dcSTX peak at 16.88 min, SIR monitoring at
m/z= 257.2. (B) No NEO peak was observed, SIR monitoring at m/z= 316.1. (C) STX peak at 16.18 min, SIR
monitoring at m/z= 300.1.
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4.1.2 PSP Toxin Standards
The PSP toxin standard solutions were prepared and injected individually
into the LC/MS system. The SIR chromatogram was generated for each toxin
peak from the toxin standards injected according to its quantifier ions (m/z),
which are recommended as ions by Quiliam (96) and Diener (3) to monitor in
selected ion monitoring (SIR) experiments listed on Table 4.1 (Figure 4.3).
Each spectrum gives the abundances of the quantifier and fragment ions
for each toxin prepared in HCI solvent (Figure 4.4 and 4.5). STX, NEO and
dcSTX produced protonated [M+H]+ ions as the quantifier ions in their spectra,
while the fragment ions were the result of losing a water molecule from the
parent ions. The spectra showed that different fragmentation pattern occurred
with the two epimeric pairs of gonyautoxins: GTX-1 and -4, GTX-2 and -3. The
abundant ions in both GTX-1 and -4 contained the fragment ion (m/z= 298.20)
due to the loss of SO3, H2O and NH3, while the other abundant ion (m/z= 332.00)
was fragmented from GTX-1 by losing SO3 and the one for GTX-4 was
protonated as [M+H]+ ions (m/z= 412.50). For GTX-2 and -3, the abundant ions
in both contained the fragment ions (m/z= 298.20) due to the loss of SO3 and
H 2 0. Another abundant ion of GTX-2 was formed by losing a SO3 to become
m/z=316.10 while GTX-3 produced the protonated ions (m/z = 396.1). It is noted
that the proportion of abundant ions for each toxin can be different depending on
the effect of different types of matrix, though it should be similar.
Most of the protonated ions were selected for SIR monitoring and
quantitative analysis for the experiment, including STX, NEO, dcSTX, GTX-3 and
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GTX-4. Only the fragment ions from GTX-1 and -2 were chosen for
quantification.
Every toxin was separated by approximately one minute except for NEO
and STX, which eluted very close to each other. Chromatographic co-elution was
not considered to be a problem since each toxin is monitored at its own m/z
using the selected ion recording (SIR) mode. As mentioned in the previous
section, the smaller peak at m/z= 316.1 only appears in the NRC STX standards
as impurity. No small peak was found on the SIR chromatogram monitored at
m/z= 316.1 from the NRC NEO standards in Figure 4.3 F.
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Figure 4.3. SIR monitored chromatograms of each individual toxin standard. (A)
GTX 3 at m/z= 396.1. (B) GTX 2 at m/z= 316.1. (C) GTX 4 at m/z= 412.5. (D)
GTX 1 at m/z= 332.0. (E) dcSTX at m/z= 257.2. (F) NEO at m/z= 316.1. (G) STX
at m/z= 300.1.

Compound

Retention Time
(min)

m/zof
quantifier ion

m/zof
fragment Ions

Gonyautoxin 1 (GTX1)
9.7
332.00
298.10
Gonyautoxin 2 (GTX2)
9.9
316.10
298.10
Gonyautoxin 4 (GTX4)
12.9
412.50
298.10
Gonyautoxin 3 (GTX3)
13.5
396.10
332.00,298.10
Neo-Saxitoxin (NEO)
15.9
316.10
298.10
Saxitoxin (STX)
16.2
300.10
282.10
dc-Saxitoxin (dcSTX)
16.9
257.20
239.20
Table 4.1. Retention time of each toxin with corresponding quantifier m/z and
fragment m/z monitored by SIR.
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180

0~yi i n |'( i rt | 11 n [ 11'i ryj r TT p TT i^y TT ri fT'riT frrt^y'TTTT f n rr|'iT't'T | r m |'TTTT|"TTI I p i 11 | 11 11 | m/Z

(C)

316.10
29032

0-^|iiii |i ill | n i i | i n i | i i M | i i i l | i n i | nil |i n i | i n i | i i i i|in i | i i i i | i n i | ii M | I I ) I | I I I I |i m/2

(B)

Feb05_PSP_STD15 547 (13.619)
298.10
100 n
142341

Feb05_PSP_STD09 676 (16.832) Cm (639:823-489:565x1.500)
257.20
1002101341

240

0-l| ii n | i i i i | in i |n 11| l i n | i n l | i M i| ii h |i n 11 in i| in

(A)

eb05_PSP_STD15 402 (10.007)
316.10
440092

100 n

r

280

300

320

II 11 • 1 1 l | I T T ! | T l T l | T I I i y T T r T

260

260

280

300

320

34

1 1 1 1 r 11 a i 1 1 1 1 1 1 1 1 1

340

260

280

300

320

340

360

380

280 300

i • I • ••• I • • • • I • I I I J 11

240 260

tH

400

320 340 360 380 400 420 440

l|llll|IMI|llll|IM!

412.50
634
i m/z

.01 e4

| I II I | II 1 1 | 1! II | I I I I | I I IT | Ml I | II I I | i r i| i f ii 11 ii 11 ii 11 |i 111| 1111| 11 ii 11 ii 111 ft\fZ

Feb05_PSP_STD12 517 (12.872) Cm (507:534-469:493x1.500)
298.10_
100
10064 |
m \

240

298.10
34661

Feb05_PSP_STD12 387 (9.634) Cm (370:411-313:352x1.500)
332.00
100m \
172422

Figure 4.5. Mass spectrum extracted for an individual toxin at its retention time. The library displayed for each PSP
toxins contained two or more m/z ratios as their abundant ions: (A) NEO; (B) GTX 1; (C) STX; (D) GTX 4.

240

282.10
4729856

Feb05_PSP STD03 651 (16.209)
._.
300.10 .
100\W
6527360

04
240

298.10
4482048

Feb05_PSP_STD06 637 (15.360)
316.10
100(A)
17776640

4.1.3 Evaluation of the Effect of Mussel Matrix on Toxin Signal
It is important to investigate how changing the proportions of the chemical
composition of a biological matrix could affect the signal for the toxin, which in
turn could lead to inaccuracy in quantification. The samples being analyzed and
compared in this experiment were the 1 ppm STX standard solution from FDA, a
mussel sample #08-29 containing STX toxins and a diluted (1:1) aliquot of the
mussel sample #08-29.
The parent peak of the 1 ppm STX standard eluted at 16.1 min (Figure
4.6 C). The significance of the result is that no STX peak was found in the
undiluted mussel sample #09-29 due to matrix effect (Figure 4.6 B). In contrast,
the more diluted mussel sample #08-29 showed a STX peak (Figure 4.6 A).
These results indicate that sample dilutions may be required for quantitative
analysis of STX in mussel samples. In addition, removal of interferences in the
matrix may be required to achieve optimal MS detection and better sensitivity.
Thus, it was necessary to develop an effective sample clean-up procedure for
removal of interferences. In the early stage of method development, no
centrifugal filter device (Amicon or Microcon) was used for sample clean-up. After
analyzing several mussel samples, a significant increase in the backpressure of
the HPLC system was observed. It was postulated that some of the matrix
components from the mussels may have precipitated and clogged the inlet frit of
the LC system causing the observed change in pressure. This conclusion was
based on the observation that the column could be restored by backflushing with
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a strong ammonium buffer and water for approximately 6 hours at a flow rate of
0.2 ml/min, after which time the pressure returned to its normal level.

1: SIR of 2 Channels ES+
300
1.34e5

testingSep22_5ul_STX06_HILIC
100-

16.0416
2.D0
4.00
testingSep22_5ul_STX04_HIUC

6.00

8.00

10.00

12.00

14.00

6.00

18.00

20.00

22.00

24.00

4 4 2

100-

11 i n T i !

1 1 1 i 1 1 1 1 i 1 1 1 i i ! 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 i 11 1 1 1 i • | i i i • 11 i 1 1 1 1 1 1 1 1 • 1 1 1 ! 1 1 1 >

2.00
4.00
testingSep22_5ul_STX03_HILIC

6.00

0.00

10.00

12.00

14.00

1 1 " " I Mil

6.00

100n

26.00
28 00
1: SIR of 2 Channels ES+
300
9.73e4

| M I l|MI l|ll ll|ll ll|ll ll|l lll|l lll|l lll| llll| llll| M M |l

18.00

20.00

22.00

24.00

26.00
28.00
1: SIR of 2 Channels ES+
300
7.01e4

(C)

0 ' i M 11

1111 |-|li i 11111 11111 1111 11111 111111111 11111 11111 111111111 11111 i iTT

2.00

4.00

6.00

8.00

10.00

12.00

14.00

1600

Jin 11 H I i frm<iv*iT\Ti\11
11111 j11 i i | 11 ii11nip¥W¥fPFw Time
18.00
20.00
22.00
24.00
26.00
28.00

Figure 4.6. SIR chromatograms monitored at m/z=300 for STX. (A) A small STX
peak at 16.04 min was observed in diluted 1:1 HCkmussel extract containing
STX. (B) No STX peak was observed in the same undiluted mussel extract
containing STX. (C) A large STX peak at 16.13 min was observed for the 1 ppm
FDA STX standard solution.
A further investigation of the effect which the matrix has on the signal for
STX was conducted by preparing a series of dilutions of a single mussel extract
(no toxins detected in this sample by LC/MS) followed by spiking the same
amounts of toxin standard mixture solutions into equal volumes of each dilution.
Figure 4.7 presents the signal variations of the STX and NEO toxins
detected in a group of successive mussel extract dilutions spiked with equal
amounts of STX and NEO standard solutions. As expected, the toxin standard
which does not contain any mussel matrix (toxin only sample) gave the highest
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STX and NEO signals while the most diluted mussel extract (1:180) had toxin
levels which were similar to the toxin signal pf the toxin standard solution. In
contrast, the matrix for the least diluted mussel (1:20) had the largest impact on
the toxin signal. The trend observed was that the more diluted the mussel
extract, the higher the toxin signal produced. The outcomes of this experiment
indicated that the mussel matrix contains interfering species that greatly
suppress the MS signal of the toxins. By diluting the matrix sample, the
concentration of the interferants is reduced, thereby improving the toxin response
significantly.
Two factors should be taken into account when establishing a suitable
dilution factor for mussel sample preparation. It is, of course, desirable to reduce
signal suppression as much as possible by diluting the matrix. However, it is also
necessary to maintain a sufficient toxin concentration (above the LOD for MS
detection) for quantitative analysis, which limits the overall sample dilutions.
Based on this study, it was decided that a reasonable compromise was to
perform a 1:40 dilution of the mussel extract prior to analysis.
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Figure 4.7. MS responses of STX and NEO in a series of dilutions of mussel
matrices spiked with equal volums of the same concentration of toxins. Note: "0"
(Toxin only) only contains STX and NEO toxin standards prepared in 0.003 M
HCI solvent which served as a control.

4.2 System Suitability
The column pressure of the HPLC system should be consistent overtime.
A large increase in column pressure, beyond the normal operating pressure, is
an indication of problems occurring in the chromatographic system. An increase
in back pressure is likely caused by the accumulation of particulates and/or
precipitation of components from the sample matrices, buffer salts used to
prepare the mobile phase, and/ or build-up in the pre-filter or the pump check
valve. The most likely contributor is the mussel extract which contains large
protein molecules that can precipitate and possibly other species that can
potentially clog the analytical column. Therefore, a pre-filter was installed
between the injector and the analytical column to remove contaminants and to

allow clean sample to travel into the column. In addition, a guard column, which
was packed with the same material as the ZIC-HILIC column was placed after
the pre-filter. The purpose of installing the guard column is to prevent chemical
contamination of the analytical ZIC-HILIC column. In addition to these
approaches to protect the analytical chromatographic column, the sample
preparation method was developed to improve the responses for the analytes of
interest and to minimize the effect of the mussel matrix on the column. The
complexity of the mussel matrix made the development of a clean-up method
necessary to prolong the lifetime of the column and to remove interferences for
MS detection to improve the analytical sensitivity. The buffer salt used for this
LC/MS analysis, ammonium formate, is insoluble in a high concentration of
organic solvent. The initial/final gradient (by volume) contains 64% acetonitrile
and 18% of 15 mM ammonium formate/15 mM formic acid. If the combination of
the formate salt and acetonitrile remained in the column over a period of one
week, the back pressure in the chromatographic system increased. For this
reason, the column needed to be flushed with a storage solvent composed of
64:36 (v/v) acetonitrile/ water without adding any buffer salts while this particular
column was not being used. Furthermore, pressure also increased when the
pump check valve was impaired by contamination, which could be solved by
sonicating the valve with diluted formic acid, or replacing it with a new one. It was
noticed that column pressure decreased occasionally due to leaks in the
system's fittings, or more commonly, due to air bubbles in the solvent line.
Replacement of tubing and other connecting parts proved to be a viable solution
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for the loss of pressure. Dry and wet priming were also performed daily to ensure
no air bubbles were entering the chromatographic system.
In order to determine the number of theoretical plates (N) and tailing factor
(T), the peak width was measured for each toxin peak. For this particular method,
the NEO peak was chosen for determining both factors. As mentioned before, a
second peak was found in the NRC STX standard solution and also in the
mussel extract as impurities when monitored at m/z= 316.10 in the SIR
chromatograms. In the SIR chromatogram monitored at m/z= 316.10, the major
peak used for quantitation of NEO eluted 1.6 min before the second peak. It was
later proved that the second peak that eluted after the major peak should not be
considered for quantitation of NEO because no peak at m/z= 316.10 was found
in the NRC NEO standard solution at the same retention time of the second
eluting peak. If the band is broadened, the larger the peak width is, the smaller
the N will become. Therefore the peak width should not be too large causing N to
be smaller than 4000. The tailing factor was calculated by measuring the front
and back half-width at 5% of the peak height. For the NRC STX standard, if the
back half-width of the NEO peak was larger than the front half-width by 1.5 min,
the smaller peak would become the peak tail of NEO. Therefore, the tailing factor
for NEO was limited to being less than or equal to 2, this standard limit was then
applied to other toxin peaks as well. This tailing factor showed the peak was
sufficiently symmetrical and could be quantitated properly. The acceptable value
of N was determined by measuring the peak width of NEO which avoided the
major peak eluting too closely to the smaller peak resulting in overlap. The

retention times of the toxins were found to vary within +/-0.5 minutes over the 9
months of chromatographic runs, which could possibly be due to matrix effect. In
addition, a shift in retention time of toxins (approximately 1 min) was observed
after the instrument service was performed by Waters after the red tide season.
Based on these evaluations, the chromatographic parameters were
established and are shown on Table 4.2.
Parameters

Established Limits

Capacity factor (k')

k'> 2.0

Retention Time (t)

Within +/- 0.5 min for this column over 9-month of
analysis

Tailing factor (T)

T<2

Theoretical plates (N)

>4000

Table 4.2. Chromatographic parameters established for the analysis.
Another critical system performance criteria for the HPLC system is the
ability to reliably and precisely deliver mobile phase for separation of the analytes
of interest. The delay volume is the volume between the gradient mixer and the
column inlet. The delay volume is comprised of the volume of the tubing between
the gradient mixer and the pump, the pump, the tubing between the injector and
the pump. The total volume was measured by programming a linear gradient and
measuring the time from the programmed time of this step to the time at which
the mobile phase change. This is the volume by which the onset of any gradient
is delayed.
The chromatogram indicated that the elution time of acetone (assumed to
be unretained) was 1.2 min at a mobile phase flow rate of 0.2 ml/min (Figure
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4.9). The time taken for the start of acetonitrile gradient to reach the MS detector
was 4.5 min based on the chromatogram, although this gradient was
programmed to start at 0 min. By subtracting 1.2 min from 4.5 min, the time taken
for the gradient front to reach the head of the column was 3.3 min (Figure 4.8).
The delay volume for the chromatographic system was calculated to be 0.66 ml.
Based on these results, all of the toxins of interest experience the gradient within
the gradient program. In our case, GTX 1 was the first to elute at 9.7 min and
dcSTX was the last peak that elutes at 16.9 min, which were within the gradient
zone before re-equilibration with the initial mobile phase, beginning at 23.30 min.
The reason for determining the delay volume is that the developed gradient
method can easily be passed on to other instruments and also to confirm that the
toxins experience gradient elution conditions.

Acetone elution time:
1.2 min

Figure 4.8. Schematic diagram of mobile phase flow in the LC/MS system with information used to calculate the gradient
delay volume.
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Figure 4.9. SIR chromatograms monitored at (A) m/z= 59 for acetone, which eluted at 1.12 min indicating the void
time and m/z= 42 for acetonitrile, which indicated the time taken for the front of mobile phase gradient (100%
acetonitrile) to reach the detector at 4.5 min.
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Calibration of the MS system must be performed annually as per the
manufacturer's recommendation. A reference solution (sodium cesium iodide
solution) containing several compounds having known m/z is used to calibrate
the mass range. The intensity and m/z of each toxin needs to be monitored
regularly on the tune window for consistency and sensitivity by directly injecting
pure standard into the MS nebulizer. The general solution to any dramatic
decrease in MS response is to clean the sample cone and the cone gas nozzle,
especially when there is a visible evidence of fouling. Since the analyte and
solvent ions are drawn through the sample cone aperture into the ion block, from
where they are then extracted into the analyzer, cleaning helps to remove
potential contaminants that accumulate near the aperture and to reduce adduct
ions in the cone gas flow.
4.3 Method Validation
4.3.1 Percent Recovery
This study was undertaken to evaluate the percentage of toxin loss during
the sample clean-up process. The percent recoveries were calculated for over
fifteen mussel samples obtained on different dates and from different sampling
sites. As displayed in Figure 4.10, the results indicated that the percent
recoveries of the toxins from the mussel extracts were within the acceptable
limits. The STX and NEO toxins were recoverable throughout the entire clean-up
procedures well within the accepted limit of 80-120%.
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Figure 4.10. Results of experiments performed to evaluate the percent recoveries
of STX and NEO in mussel samples throughout the clean-up process.

4.3.2 Precision
To verify the ability of the operating instrument to produce consistent data,
consecutive injections of a toxin containing mussel extract were performed. A
mussel extract (blank) was selected and distributed into two aliquots: one was
spiked with a toxin standard mixture containing STX, NEO and dcSTX; the other
was spiked with a standard mixture containing GTX-1, -2, -3 and -4. The RSDs
for all toxins analyzed were within + 20%, over the time required to run eight-30
min runs (Table 4.3). The results showed that the instrument is able to generate
reproducible responses for the toxins in the mussel extract over eight successive
injections. It is noted that the RSD for the GTX 4 toxin was higher than observed
for the other toxins. Because of the low MS sensitivity for GTX 4, any fluctuations
in the low response range can cause a higher RSD for the eight injections
(Figure 4.11). The results for GTX 1 and 2 were displayed on a separate graph

since the signal scale was higher than the scale of the all of the other toxins
(Figure 4.12).
Toxins

RSD (%)

STX

3.2

NEO

6.0

dcSTX

3.6

GTX1

1.1

GTX2

0.56

GTX3

4.9

GTX4

14

Table 4.3. Relative standard deviation (%) of the PSP toxin concentrations
obtained for eight injections of spiked mussel matrices with standard toxin
mixtures.
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Figure 4.11. Graph illustrating the responses from eight consecutive 5 uliniections of the PSP toxins (STX, NEO, dcSTX, GTX 3 & 4) in the mussel matrix.
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Figure 4.12. Graph illustrating the responses from eight consecutive 5 ulinjections of the PSP toxins (GTX 1 & 2) in the mussel matrix
4.3.3 Estimated Limits of Detection and Quantitation
The LODs and LOQs for each toxin were estimated by evaluating the S/N
for the toxins in 0.003 M HCI solution and in diluted mussel extract. The mussel
extract used for this experiment was previously analyzed with none of the seven
PSP toxins of interest detected. Each of the HCI solutions and the diluted mussel
extract was spiked with two groups of toxin standard mixture respectively (see
section 3.3.3 for toxin content). The concentrations of the toxins (in ppb) at their
LODs and LOQs in the HCI solvent and in the diluted mussel extract (1:40
dilution) are shown in Table 4.4. The LOD indicates the lowest concentration of
toxin that can be detected and the LOQ is the lowest level at which reliable
quantitation can be performed. The LOD and the LOQ are expressed in
concentration units (ppb) at a signal-to-noise (S/N) ratio of 3:1 and at a S/N ratio
of 10:1 respectively. The LOD and LOQ of the GTXs were found to be
approximately a factor of 10-100 higher than all of the other toxins investigated
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for this experiment. STX, NEO and dcSTX had the lowest LODs in the diluted
mussel extract. The LODs and LOQs presented on Table 4.5 are converted to
the values in the original mussel extract accounting for the dilution factor of 1:40.
The units are still expressed in ppb (=ng/ ml).
For comparison, the LOD for PSP toxins when using the mouse bioassay
method is equivalent to 44 ug STX equivalents/100 g meat. Table 4.6 shows the
LODs of all toxins obtained by the LC/MS method converted to ug STX
equivalents/100 g meat by taking in account the toxicity factors and dilution
factor (1:40). Only STX, NEO and dcSTX have the LODs which are lower than 44
ug STX equivalents/100 g meat. Therefore, improvement of the LODs for the
four GTX toxins will be necessary.
It should also be noted, the degree of suppression of MS signal varied
between different batches of mussel samples based on the different lots of the
same matrix, the origin of mussels, and the date of collection. As a result, toxin
signals varied to a small extent and thus the LOD and LOQ values stated are
estimates (97).

9.0
106

0.90
26.4
11.4
30
552

dcSTX

GTX1

GTX2

GTX3

GTX4

276

552

276

30

45.6

52.8

4.5

1.7

1.6

extract (1:40)

In diluted mussel

Table 4.4 Estimated limit of detection (LOD) and limit of quantitation (LOQ) expressed in concentration units (ppb)
for each PSP toxin in HCI solvent and in diluted mussel blank. The mussel blank was diluted to 1:40 after spiking
with the toxin standard mixtures. The concentrations listed were the injected concentrations with an injection
volume of 5ul. Note: ppb is also expressed as ug/ ml.

15

5.70

13.2

0.24

0.16

0.16

In HCI solvent

60

91.1

3.3

0.33

NEO

3.2

extract (1:40)

In diluted mussel

0.32

In HCI solvent

S/N>3

S/N > 10

STX

Toxins

LOD (ppb):

LOQ (ppb):

Toxins

Concentration at LOQ, S/N>
10 (ppb in original mussel)

Concentration at LOD, S/N> 3
(ppb in original mussel)

64
STX
1.3x10*
1.3x10*
68
NEO
3.6x10*
1.8x10*
dcSTX
a
GTX1
4.24 x10
2.11 x10 a
3.64 x10 3
1.82 x10 3
GTX2
1.2 x10 3
GTX3
2.4x10*
GTX4
2.21 x10 4
1.10x10 4
Table 4.5 . LODs and LOQs of the seven PS 3 toxins in original mussel extract.
Note: concentration is expressed in ppb (ng toxins/ g mussel).

Concentration at LOD
(ug STX equivalents/100 g meat):
Toxins

LC/MS method

Mouse bioassay method

(estimated LOD values)
STX

6.4

NEO

6.3

dcSTX

9.2

GTX-1

210

GTX-2

65.5

GTX-3

77

GTX-4

802

44 for £PSP equivalents

Table 4.6.Estimated limit of detection (LOD) of toxins by the LC/MS method and
the mouse bioassay method expressed in the concentration unit (ug STX
equivalents/100 g meat).

4.3.4 Linearity
A 5-point calibration curve for each of the 7 toxins was generated to
evaluate whether the MS response changes linearly with the concentrations of
toxins in mussel extract. In order to display all of the calibration curves on one
graph due to the large variations in concentrations of the toxin standards, the
dilution factors for the toxin standard stock solutions are plotted on the x-axis, as
shown in Figure 4.13. Table 4.7 provides the corresponding concentrations for
each toxin.
The acceptable correlation coefficient was deemed to be at least 0.995
specifically to the biological samples for measuring how well the linear regression
fit to the set of data. This correlation factor was determined according to the
FERN method for food analysis. The calibration curves for STX, NEO, dcSTX,
GTX-1, -2 and -3 were established with a r2 larger than 0.995. Due to the low
sensitivity of GTX 4, a series of five concentrations were not able to develop a
calibration curve with a satisfied correlation factor. Therefore, quantitative results
cannot be obtained for GTX 4 unless the concentration of GTX 4 in the mussel
extract is very high and/or otherwise the MS sensitivity for GTX 4 must be
improved.
The standard calibration curves demonstrate that there exists a linear
relationship between the MS responses and the concentrations of toxins (all but
GTX-4) with the acceptable r2. Hence, the PSP toxins in shellfish can be
quantitated reliably within the range of calibrated concentrations (Table 4.7).

Dilution Factor
1/8

1/16

1/4

1/2

1

Concentration of toxins (ppb) in mussel at the
designated dilution factor
STX

128

252

520

1000

2040

NEO

132

264

520

1040

2120

dcSTX

88

180

360

720

1440

GTX1

2110

4240

8440

16920

33800

GTX2

3640

7280

14600

29200

58400

GTX3

1200

2400

4800

9600

19200

Table 4.7. Conversion of dilution factors of PSP toxin standards to the actual
concentrations for calibration curves. Note: ppb is also expressed as ng/g.
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Figure 4.13. Standard calibration curves for the toxins in mussels. For the actual
concentrations of toxins, refer to Table 4.7.

4.4. Stability Studies
4.4.1 Evaluation of Toxin Stability of Mussel Extract in the LC Autosampler
The stability of processed samples in the LC autosampler was examined
over the anticipated run time of a sample batch (approximately 32 hours for the
total of 8 repetitions). One aliquot of a mussel sample containing both STX and
NEO toxins was used for setting up a quantitative sample set (see section 2.3.6
for sample set method) and was run repetitively for eight cycles. Each cycle had
a run time of 4 hours, resulting in a total of 32 hours to complete eight cycles.
The PSP toxin concentrations for each set were measured.
The graph in Figure 4.14 the concentrations of each of the toxins, STX
and NEO in the mussel extract for repetitive analyses over the 32-hour period of
the experiment. It was found that the concentration of NEO had an average of
362.0 ppb ± 3.6%, was about 2.2 times higher than the concentration of STX
which had an average of 162.7 ppb ±11.2%.
To compare this result to what is acceptable for the mouse bioassay, the
LC/MS results were converted from ppb (= ng/ml) of specific toxins to ug STX
equivalents/100 g mussel meat. The average concentration of the replicated
sample set was calculated to be 497.3 ug STX equivalents/100 g mussel meat
accounting for the STX and NEO toxins (Figure 4.15), with a relative standard
deviation of 4.7%, which is within the acceptable range of ±20% according to the
FERN method. This experiment indicated that a processed sample placed in the
instrument for a 32-hour period was able maintain stability within an acceptable
variability in toxin level.
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4.4.2. Evaluation of Long Term Stability of Mussel Extract
According to the NHPHL bioassay procedure guidelines, the bioassay
must be performed on the mussels and the results should be reported within 24
hours after the mussels are received from the environmental services (27). This
study was undertaken to determine whether a mussel extract containing toxins is
stable beyond the 24-hour period in case of any mussel samples need to be reanalyzed.
The stability of the toxins in a frozen mussel extract (sample #09-13)
containing STX and NEO was evaluated over a 3-month period. The mussel
extract received from the bioassay lab was aliquoted and stored in 1.5-ml vials at
-29°C. Periodically, from July through September 2009, a frozen aliquot was
thawed and prepared for a sample set for quantitative analysis. The results
showed that the STX varied in concentration with a RSD of 15.5% over three
months, whereas the RSD for NEO was 20.1%. The data suggested that STX
maintains a more stable concentration over the 3-month period. A plot of
concentrations of the two toxins against the time period exhibited no particular
trend in variability (Figure 4.16).
The overall toxin levels measured for the mussel samples over this time
period was converted from the ppb unit (= ng toxins/ g mussel meat) to ug STX
equivalents/100 g meat. The results ranged from 60 to 80 ug STX equivalents/
100g mussel meat (Figure 4.17). The results had a RSD of 13.8% over a threemonth period for the mussel sample stored at -29°C. It is noted that mussel
sample must be analyzed within the 24 hour period after arriving at the NHPHL
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lab. This information is useful to know when the sample needs to be re-analyzed
after the 24 hour period.
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4.4.3. Evaluation of Toxin Degradation in Standards
To confirm that the PSP toxin standard solutions are suitable for producing
reliable quantitative results, the stability of the standard solutions obtained in
September 2008 (1-year-old) and September 2009 (new) were evaluated. The
stability assessment was conducted in December 2009. The results of the toxin
standards acquired from the two different years were compared.
Based the SIR chromatograms monitored at m/z= 300.1, the STX peak
area of the 2008 standard was 4.9% lower than the STX peak of the 2009
standard indicating that it is possible that degradation of the standard has
occurred over a year of storage at -29°C. Similarly, the SIR chromatogram at
m/z= 316.1 showed that the NEO peak area of the 2008 standard was lower than

the NEO peak area of the 2009 standard by 2.6%. The stability studies
conducted by Alfonso et. al. indicate that degradation occurred over the period of
a year when the standards were stored at -20°C although STX was more stable
than NEO (98). Over the course of the 2009 red tide season (April through
October) while using the toxin standard (2008) for quantification, both STX and
NEO maintained stability with the tolerable loss of less than 4.9% and 2.6%
respectively.
4.4.4 Investigation of Toxin Degradation during the Sample Preparation
Process
The routine sample extraction process involves using 0.18 M HCI as a
solvent to extract toxins from the mussels, followed by heating the mixture to
boiling for 5 minutes. This assessment was performed to evaluate the effects on
the toxins of using water and HCI as extraction solvents and by varying the
heating time during the sample preparation process.
Two batches of mussels originating from Canada were purchased in July
and December from a local supermarket (Concord, NH). About 15 mussels were
selected, blended and processed through the homogenate step, followed by
spiking with two sets of PSP toxin mixtures (STX, NEO and dcSTX in one set,
and GTX1-4 in another set), resulting in two aliquots of homogenate spiked with
two separate groups of toxin mixtures. By further dividing each aliquot into two,
one of each was combined with water and the other mixed with 0.003 M HCI,
resulting in four aliquots.

Based on the experiments conducted in July and December, the STX
signal was slightly higher when the mussel extract was prepared in HCI
compared to water. The extraction efficiency seemed to be higher for HGI
solution.
The STX levels in a boiled mussel extract in acid at 0, 5, 10 and 30 min
were difference between 0 and 5 min, 5 and 10 min, 10 and 30 min. These
percent differences were -19.7%, -3.7% and 8.8%. As shown in Figure 4.18,
there was no observable trend in STX level variation noted for different boiling
times. However, no GTXs were detected in the mussel extract or appeared to be
generated from the process of heating in either of the solvents (HCI or water).
After the boiling process, no STX, NEO or dcSTX toxins were found in the
mussel extract spiked with the GTXs toxins, or vice versa. Therefore, no
conversion between the group of GTXs and the group of STX, NEO and dcSTX
were observed throughout the sample preparation process. Based on the results,
the evaluated PSP toxins did not seem to degrade. However, when using HCI as
an extraction solvent, it is possible that the undetected amounts of the Nsulfocarbamoyl toxins (e.g. C1-4) present in the mussel may have converted to
the carbamoyl toxins of interest such as STX, NEO, GTX 1-4, but in undetectable
levels.
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Figure 4.18. Graph indicating the trend of STX signal versus the duration of
heating of the homogenate to boiling in HCI solution.
4.5 Cross-Validation Studies for Amicon and Microcon devices
An improved centrifugal filtration device, Amicon, was manufactured to
replace the device that employs the gravitational concept for filtration - Microcon,
by Millipore. This experiment was performed to determine whether the results
obtained using the two devices for sample clean-up are similar. Triplicates of
mussel extract spiked with toxin standard mixture 1 and 2 (see section 3.5 for
details) prior to and after the sample clean-up were prepared and processed
through the clean-up procedures using 12 Amicon and 12 Microcon tubes.
Results including percent recoveries of the 6 PSP toxins using Microcon and
Amicon devices for sample clean-up procedures are reported on Table 4.8. Total
toxin levels (units in STX equivalents/ 100g meat) were determined in the spiked
mussel extracts using both filter devices. The percent recoveries for all of the
PSP toxins using the two devices were found to be within the acceptable range

of 80 to 120%. No results were acquired for GTX 4 due to the low sensitivity of
the MS signal for this toxin.
The percent difference was found to be 9.8% when comparing the
average toxin concentration of the triplicates, for the extract spiked with standard
mixture 1 from using the Amicon and Microcon devices. For the extract spiked
with standard mixture 2, the percent difference was 6.8% between the two
devices. Additional comparison between the results obtained using the Amicon
and Microcon devices could not be performed since the Microcon tubes are no
longer available for purchase. The deviation in the results between the two filter
devices was deemed to be acceptable, so we continued to use the Amicon
device for sample clean-up for sample analyzed after mid-September of 2009.

Spiked with Standard
Mixture 2
(GTX-1,-2,-3,-4)

172
177
189
179
8.26

1098
1061
834
998
142.7

Spiked with Standard
Spiked with
Standard Mixture 2
Mixture 1
(GTX-1,-2,-3,-4)
(STX, NEO and dcSTX)
ug STX Equivalents/100 g mussel meat

ug STX Equivalents/100 g mussel meat
206
1024
197
983
193
797
199
934
6.38
121

Spiked with Standard
Mixture 1
(STX, NEO, dcSTX)

STX
102.7
99.2
97.5
99.8
2.7

STX
103.0
99.6
104.1
102.2
2.3

NEO
98.9
93.9
95.4
96.0
2.6

NEO
102.5
92.6
98.4
97.8
5.0

GTX-1
99.1
100.0
90.8
96.6
5.1

dcSTX
99.8
99.5
101.6
100.3
1.1

GTX-1
101.2
100.5
100.9
100.9
0.3

Percent Recovery

dcSTX
96.5
97.5
102.2
98.7
3.1

Percent Recovery

GTX-2
101.3
102.9
95.5
99.9
3.9

GTX-2
104.0
107.6
89.4
100.3
9.7

GTX-3
88.1
102.0
101.5
97.2
7.9

GTX-3
99.2
102.5
93.3
98.3
4.7

Table 4.8. Results using Microcon (top) and Amicon (bottom) devices for the sample clean-up. Triplicates of spiked
mussel extract with toxin mixture 1 and 2 were prepared prior to and after sample clean-up using Microcon and Amicon
devices. Toxin levels expressed in the unit of ug STX equivalents/100 g mussel meat were reported for both devices.
Percent recoveries of the six PSP toxins were also reported.

Sample Prep
1
2
3
Avg
STD DEV

AMICON

Sample Prep
1
2
3
Avg
STD DEV

MICROCON
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4.6 Qualitative and Quantitative Analyses of PSP Toxins in Mussels
4.6.1 Toxin Profiles of Mussels from NH Coastal Waters during the Summer
of 2009
During the red tide season from April to October 2009, the concentrations
of the PSP toxins in mussels harvested from Hampton Harbor and the Isles of
Shoals were determined by the LC/MS method developed and the mouse
bioassay method on a routine basis. The LC/MS method is able to detect several
PSP toxins in the mussel samples. The toxin profiles for mussels reflect the
conditions of mussels being exposed over the period of collection. The toxin
levels can vary depending on the geographic locations and the types of algae
present (99). The LC/MS results indicated that the STX and NEO toxins were
present in most of the mussel samples obtained from both NH coastal locations.
The concentrations of STX and NEO determined to be present in the mussels
were converted to the unit of ug STX equivalents/100 g meat and compared with
the toxin levels determined by mouse bioassay.
Using the developed LC/MS method for toxin analysis, all mussel samples
were screened for the presence of toxin peaks with a S/N> 5 prior to performing
a separate experiment for quantitation. If the results of the screening experiment
resulted in a S/N < 5 for all of the toxins, no quantitation was performed for the
sample. The results in detail for the toxin levels (ug STX equivalents/ 100g meat)
found in all mussel samples from Hampton Harbor and the Isles of Shoals during
the summer of 2009 are given in Tables 4.9 and 4.10.
The toxin levels detected by the bioassay and the LC/MS method in
Hampton Harbor varied over the entire red tide season from April to October as

shown in Figure 4.19. Only one sample exceeded the FDA actionable limit at 80
ug STX equivalents/100 meat by the bioassay method, leading to closure for
shellfish harvesting. The bar chart presented in Figure 4.19 shows that all of the
toxin levels determined by the bioassay were higher than the levels produced by
the LC/MS method. The LC/MS method does, however, detect PSP toxins in
some of the mussels below the bioassay detection limit of 44 ug STX
equivalents/100 g meat.
For mussels from the Isles of Shoals, the PSP toxin levels reached 80 ug
STX equivalents/100 g shellfish meat a few times in May and July 2009. The bar
chart given in Figure 4.20 shows variations of the toxin levels obtained by the
bioassay and the LC/MS methods over the summer of 2009. Several
observations are common for both sampling locations. The toxin profile of the
mussels harvested from the Isles of Shoals and Hampton Harbor both showed
the presence of STX and NEO. When the toxin level reached above 80 ug STX
equivalents/100 g meat, the toxin levels measured by the two methods were
more comparable. One explanation for the difference between the two method is
that the mouse bioassay may be sensitive to other toxins not detected by the
LC/MS. Another reason for the differences observed in the results between the
two methods could be due to the high LODs of the GTXs toxins for the LC/MS
method.

Week
#
1

LC/MS
Result (cone.

(ugSTX
equiv./
100g
meat)

of STX in ppb)

2

Sample
number
09-01
09-03

3
4

09-05
09-08

4/13/2009
4/20/2009
4/28/2009

5

09-09
09-12
09-14
09-15
09-17

5/4/2009
5/13/2009
5/19/2009
5/26/2009
5/28/2009

<44
48.6
<44
53.4
77.4

09-18
09-22
09-24

6/1/2009
6/8/2009
6/15/2009
6/22/2009

73.9
47.2
<44
<44

6/29/2009
7/7/2009
7/15/2009
7/23/2009
7/28/2009
8/4/2009

6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

09-26
09-28
09-30
09-33
09-37
09-38
09-40
09-42
09-44
09-47

Collection
date

Bioassay
result

4/5/2009

09-50
09-53

8/10/2009
8/17/2009
8/25/2009
9/2/2009
9/9/2009

09-55
09-56

9/16/2009
9/21/2009

28
29

09-59
09-60
09-62

9/29/2009
10/5/2009
10/19/2009

30
31

09-63
09-64

22
23
24
25
26
27

<44
<44
<44
<44

Result (cone.
of NEO in ppb)

LC/MS result
(ug STX equiv./
lOOg meat)

No signal
No signal
No signal
No signal
No signal
4.4

N/A
N/A

N/A
N/A
N/A

N/A
12.6

N/A
34.0

N/A
N/A

N/A
N/A
384

142
178
80.7

33.8
4.04

178
40.4

<44
<44
332

3.97
5.31
43.9

46
49
<44
<44

11.7
39.5

39.7
35.1
146
11.7
39.5

<44
<44
<44
<44

Trace, S/N<5
No signal
Trace, S/N<5
Trace, S/N<5
Trace, S/N<5

3.59
3.68

25.3
Trace, S/N<5

<44
<44

Trace, S/N<5
Trace, S/N<5

10/25/2009

<44

10/29/2009

<44

Trace, S/N<5
Trace, S/N<5

N/A

N/A
N/A

Trace, S/N<5
Trace, S/N<5
49.7
19.3
15.6

<44
<44
<44

LC/MS

3.59
3.68
N/A
N/A
N/A
N/A
N/A
253
N/A
N/A

285
81.7
173
N/A
N/A
19.5
317
11.7
39.5
3.59
3.68
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

N/A
N/A

N/A
N/A

N/A

N/A

Table ^k9. Toxin levels in m ussels fro m Hampton Harbor. Toxin Ievels given in
units of ug STX equivalents/ 100g mussel meat as obtained from mouse
bioassay and LC/MS methods. Result from the bioassay shown as <44 ug STX
equivalents/ 100g mussel meat indicate the LOD of this method. Result from the
LC/MS method shown as "trace" referring to toxin signal is being observed in
mussel sample, but having S/N<5; "no signal", indicates that no toxin is
observed in the SIR chromatograms. Results for LC/MS method also given in
ppb (ng toxins/ g mussel meat)

09-32
09-34
09-39
09-41
09-43
09-48
09-49
09-51
09-54
09-57

14
15
16
17
18
19
20
21
22
23
07/13/09
07/20/09
07/28/09
08/04/09
08/10/09
08/26/09
09/01/09
09/08/09
09/14/09
09/23/09

Collection
date
04/05/09
04/14/09
04/20/09
04/27/09
05/06/09
05/12/09
05/18/09
05/26/09
06/02/09
06/08/09
06/16/09
06/24/09
07/01/09
1583
590
222
44.8
<44
<44
<44
<44
<44
<44

Bloassay result
(ug STX equiv./
100g meat)
<44
<44
<44
47.2
74.1
103.5
97.5
63.6
76.1
49
<44
<44
<44
1048
194
22.4
9.93
4.76
No signal
No signal
Trace, S/N< 5
No signal
Trace, S/N< 5

LC/MS result
(ug STX equiv./
100gmeat)
No signal
No signal
No signal
Trace, S/N< 5
14.7
122
119
No signal
44.0
11.9
92.2
10.1
6.64
469.4
280.8
137.8
70.2
47.6
N/A
N/A
N/A
N/A
N/A

LC/MS result
(cone, of STX
in ppb)
N/A
N/A
N/A
N/A
48.0
394
257.0
N/A
179.0
22.2
216.0
55.4
52.5
1731
534.2
93.0
31.5
N/A
N/A
N/A
N/A
N/A
N/A

LC/MS
result (cone,
of NEO in ppb
N/A
N/A
N/A
N/A
107
891
1007
N/A
283.0
104.6
764.0
49.7
15.0

LC/MS result (cone, of other
toxins in ppb
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
GTX-1: 560, GTX-2: 1865;
GTX-3: 3406 in 09-32
GTX-1: 1168 in 09-34
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Table 4. 10. Toxin evels in mijssels from the Isles of Shoals Toxin levels given in units of ug STX equivalents/ 100c
mussel meat as obtained from mouse bioassay and LC/MS methods. Result from the bioassay shown as <44 ug STX
equivalents/ 100g mussel meat indicate the LOD of this method. Result from the LC/MS method shown as "trace"
referring to toxin signal is being observed in mussel sample, but having S/N<5; "no signal", indicates that no toxin is
observed in the SIR chromatograms. Results for LC/MS method also given in ppb (ng toxins/ g mussel meat).

Sample
number
09-02
09-04
09-06
09-07
09-10
09-11
09-13
09-16
09-20
09-23
09-25
09-27
09-29

Week
#
1
2
3
4
5
6
7
8
9
10
11
12
13

9

13

15

17

Week (April - Oct 2009)

11

19

21

23

25

27

Mouse
Bioassay
Detection
Limit

Shellfish
Bed
Closure!!

• Bioassay Result

• LC/MS Result

Figure 4.19. PSP levels of the mussels collected from Hampton Harbor during the period of April - October 2009.
Parallel measurements of toxin levels by the LC/MS and the mouse bioassay. All LC/MS samples prior to
September were processed using Microcon devices. Later samples were processed with Amicon devices. Toxin
concentrations found by the LC/MS method were converted to ug STX equivalents/ 100g meat.
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Figure 4.19. PSP levels of the mussels collected from Hampton Harbor during the period of April - October 2009.
Parallel measurements of toxin levels by the LC/MS and the mouse bioassay. All LC/MS samples prior to
September were processed using Microcon devices. Later samples were processed with Amicon devices. Toxin
concentrations found by the LC/MS method were converted to ug STX equivalents/ 100g meat.
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Figure 4.21 and 4.24 present the toxin composition in mussel samples for
the two sampling locations over the summer of 2009. The bar chart from each
site is divided into two plots of specific PSP toxin levels over time: Figure 4.22
and 4.23, display the change in toxin concentrations of STX and NEO,
respectively, in mussels from Hampton Harbor. Figure 4.25 and 4.26 display the
same charts for the Isles of Shoals. From April to October, the LC/MS method
indicates that NEO is the predominant toxin in most of the mussel samples
collected from both locations especially the Isles of Shoals while STX was also
found in mussel samples during this period of time. The LC/MS analysis shows
that, for one of the samples #09-32 from the Isles of Shoals, several other PSP
toxins were detected. That particular mussel sample was found to contain GTX1, -2, -3, and -4 in addition to NEO and STX.
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Figure 4.21. Toxin composition of mussels from Hampton Harbor measured by
the LC/MS method. Note: units are ppb (ng toxins/ g mussel meat).
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Figure 4.22. Concentration of STX in mussels collected from Hampton Harbor
throughout the summer of 2009. Note: units are ppb (ng toxins/ g mussel meat).
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Figure 4.23. Concentration of NEO in mussels collected from Hampton Harbor
throughout the summer of 2009. Note: units are ppb (ng toxins/ g mussel meat).
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Figure 4.24. Toxin composition in the mussels from the Isles of Shoals measured
by LC/MS method. Note: units are ppb (ng toxins/ g mussel meat).
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Figure 4.25. Concentration of STX in mussels collected from Hampton Harbor
throughout the summer of 2009. Note: units are ppb (ng toxins/ g mussel meat).
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Figure 4.26. Concentration of NEO in mussels collected from Hampton Harbor
throughout the summer of 2009. Note: units are ppb (ng toxins/ g mussel meat).
4.6.2 Special Case
In May 2009, the mouse bioassay found 1583 ug STX equivalents/100 g
meat in mussel #09-32. The LC/MS analysis showed GTX-1, -2, -3, STX and
NEO toxins were present in the sample and these toxins were quantitated.
Mussel extract #09-32 was the only sample that contained all of the GTX toxins
in addition to STX and NEO toxins, as determined by the LC/MS method. The
concentrations of all detected PSP toxins were converted into one value using
the toxicity factors shown in Table 1.2, resulting in 1048 ug STX equivalents/100
g mussel meat (Table 1.2). GTX 1 was responsible for over 50% of the overall
STX equivalents level, followed by GTX 3 and GTX 2 (Figure 4.27). In this case,
STX and NEO were the minor toxins present in this particular mussel extract
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which is different from all other mussel samples collected in the Isles of Shoals
during summer 2009.
As discussed previously, one of the possible factors which causes the
toxin level using the bioassay to be higher could be the high LODs for GTX-1, -2,
-3, and -4. Our study showed that the LOQ of GTX 1 was approximately 106 ppb
(ng toxins/ g mussel meat) in the injection volume. Accounting for the dilution
factor (1:40), the LOQ was 4240 ppb in the mussel samples. A hypothesis was
proposed which suggests that GTX toxin can possibly be present in other mussel
samples and not be detected. The calculation shows that GTX 1 may not be
quantitated if the estimated GTX concentration is lower than 4240 ppb (ug toxins/
g mussel meat) in the original sample. By converting the LOQ of GTX 1 in ppb to
the ug STX equivalents/100 g meat and accounting for the toxicity factor, the
level is about 421 ug STX equivalents/100 g meat. This concentration was
higher than the LOD in the bioassay method (44 ug STX equivalents/100 g
meat) by a magnitude of 10. Therefore, it is reasonable to suspect that GTX may
be present in any of the samples analyzed. However, another possible factor
giving rise to the difference in toxin levels between the methods could be that the
mouse bioassay may be sensitive to other toxins which are not detected by the
LC/MS method.

Figure 4.27. Distribution of PSP toxins in mussel #09-32, in % of total ug STX
equivalents/ 100g meat. All toxins were converted from the concentrations (ppb,
also ng toxins/ g mussel meat) measured by the LC/MS method to ug STX
equivalents by taking into account the relative toxicity factors given in Table 1.2.

CHAPTER 5

CONCLUSIONS AND FUTURE WORK

Application of the LC/MS method for measuring PSP toxins in mussels
was found to provide a rapid and quantitative routine monitoring tool which may
supplement the mouse bioassay for toxin detection in shellfish. The LC/MS is
useful for screening samples containing toxins at concentration (i.e.STX, NEO
and dcSTX) lower than 44 ug STX equivalents/100 g meat, the detection limit of
mouse bioassay. It provides confirmation information including the molecular and
fragment ions for each toxin detected. The concentration of selected PSP toxins
in mussel samples can also determined. Use of ZIC-HILIC liquid chromatography
provides separation of the polar PSP toxins without using ion-pairing reagents of
a highly aqueous mobile phase which may affect the MS sensitivity. The limits of
detection of the STX and NEO toxins were as low as 64-68 ppb (ng toxins/ g
mussel meat) in mussel meat using our developed method. Therefore, high
sensitivity of MS detection proved that the clean-up methodology is effective in
reducing matrix effects for the mussel matrices. In addition, LC/MS does not
require the complicated and time-consuming steps of derivatizing toxins prior to
analysis for method using fluorescence detection (100).
The detection limits of GTX 1-4 using LC/MS can be improved by other
highly sensitive techniques such as LC/MS/MS upon availability in the lab. Other
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less common PSP toxins and unknown toxins which might have resulted in the
higher toxin level obtained by the mouse bioassay method can be explored and
possibly identified in shellfish samples.
Only limited validation experiments have been conducted in this research
project due to the inadequate amounts of PSP toxin standards (0.5 ml per
ampoule of toxin). In the future, more intensive and thorough studies can be
performed with more replicates and be analyzed on a statistical basis. The effect
of matrix on the MS signal from different batches of mussels on the LOD can also
be investigated.
Parallel studies will also be carried out with the regulatory AOAC mouse
bioassay, the AOAC official instrument method, LC/FD, and the newly developed
LC/MS method.
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APPENDIX
Method for the Use by NHPHL
Using LC/MS for Measuring Toxins in Mussels

PURPOSE:
This procedure provides sample preparation and analytical analysis procedures
for common PSP toxins in mussels and for toxin screen using a Waters 2695
Alliance HPLC/Micromass ZQ Mass Spectrometer (ESI mode).
SCOPE:
This procedure is applicable to mussel matrices being screened for the following
PSP toxins: saxitoxin (STX), neo-saxitoxin (NEO), decarbamoyl-saxitoxin
(dcSTX), Gonyautoxin 1 (GTX-1), Gonyautoxin 2 (GTX-2), Gonyautoxin 3 (GTX3), Gonyautoxin 4 (GTX-4).
RESPONSIBILITY:
It is the responsibility of the analyst to note any modifications to this procedure.
DEFINITION AND ACRONYMS:
LC/MS - liquid chromatography/mass spectrometry
MS - mass spectrometry
ESI - electrospray ionization
ACN - acetonitrile
MSDS - material safety data sheet
HPLC - high performance liquid chromatography
TIC - total ion chromatogram
SIR - selected ion recording
SAFETY CONSIDERATIONS:
The chemicals that are analyzed by this method are toxic. Many of the chemicals
used in this analysis are corrosive. Use all appropriate PPE (gloves, safety
goggles, laboratory coats, masks, face shield, sleeves and boots as appropriate)
and perform all manipulations of toxins in a chemical fume hood. In addition
analysts should consult the Material Safety Data Sheets for all reagents and
standards utilized for specific precautionary measures. Ensure that others in the
laboratory are aware of the hazards and required safety precautions. Handle all
waste from sample preparation procedures and HPLC mobile phases as
hazardous waste except mussel shells and meats are not considered as
hazardous, and can be disposed of in a regular disposal bin.
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EQUIPMENT:
Waters 2695 Alliance HPLC coupled with a MicroMass ZQ mass
spectrometer (ESI mode), or equivalent
SeQuant ZIC®-HILIC analytical column (2.1 x 150mm PEEK, 3.5 urn,

200A)
SeQuant SeQuant ZIC®-HILIC guard column (2.1 x 20mm PEEK, 3.5 urn,

200A)
Shucking knives: Sterile
Scrub Brushes: Sterile
Sieve: #10 mesh or drainer for mussels
Blender
Beaker (600ml)
Evaporating dish to cover beaker
Magnetic stirring bar
Hot plate (temperature up to 100°C)
Thermometer (measure up to 100°C)
pH paper (universal or pH < 7)
Centrifuge capable of a speed of 3,000 rpm, accommodates min. 50 ml
tubes
Centrifuge capable of a speed of 14,500 rpm, accommodates 1.5- or 2.0ml tubes
Balance capable of weighing 0.0001 g and 200 g
Micropipets and tips (100 pi - 1000 pi)
2.0 ml crimp top autosampler vials with 300 pi inserts and aluminum crimp
caps lined with PTFE/silicone rubber septa
0.45 pm white nylon filters for aqueous solvents
GHP Acrodisc 13 mm Syringe Filter with 0.2 pm GHP membrane (HPLC
certified)
BD 1 ml disposable syringes with tuberculin slip tip or equivalent
Millipore Amicon Ultra 3K centrifugal devices (0.5 ml) with microcentrifuge
tubes
QC ELEMENTS:
It is the responsibility of the analyst to ensure that the instrument passes all
QA/QC requirements prior to each analytical run. In addition, a method blank
should be prepared with each analysis. A representative set of standards should
be run with each analysis set.
INSTRUMENT MAINTANENCE:
LC:
Flush column regularly (weekly), or store column in 80:20 (v/v)
acetonitrile/water when not in use
Purge syringe injector and prime solvent lines before running samples
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Prepare fresh mobile phases daily, especially buffer
Prepare wash solutions monthly, composed of water/acetonitrile in 36:64
(v/v)
Check for leaks and maintain ensure the backpressure is consistent over
time
MS:
Source maintenance: clean baffle plate, sample cone and cone gas nozzle biweekly
Instructions: 1.Remove cone parts following the directions described in the
Manual called "Operation and Maintanance of the ZQ with MassLynx". 2. Clean
the stained cone area with Q-tips, polishing powder (WAT 241066) and water if
necessary. 3. Sonicate cone parts in 10% formic acid in methanol for 20 min. 4.
Sonicate cone parts in 50:50 (v/v) methanol/water for 20 min. 5. Sonicate cone
parts in 100% methanol for 15 min. 6. Dry in air or blow-dry with N2.
Replace O-ring (Catalog.#5711321-DG 12 mm x 1.5 mm/ Black Viton,
Micromass UK LTD) on cone if found to be loose.
Pump maintenance:
a. Ballast pump weekly for 15 minutes by loosening the knob on top of the
pump to remove volatile contaminants in oils
b. Replace pump oil in vacuum system once every three months
Instruction: 1. Ballast the pump. 2. Turn off the pump by clicking "Vent" on
the MS tuning page on MassLynx. 3. Wait for 15-30 min until the pump
has cooled down. 4. Drain the oil by removing the knob facing out slowly.
5. Flush the pump with half a liter of pump oil. 5. Place the knob back to
the original position, make sure it is tightly closed. 6. Refill the oil until it
reaches the maximum level on the index.
Calibration of the mass range should be done annually
REAGENTS:
Acetonitrile: LC/MS grade or equivalent
Water: 18 M ohm water from a Millipore Milli-Q Gradient A-10 water source (or
equivalent)
Formic Acid (99% w/w)
Glacial acetic acid: HPLC grade
Hydrochloric acid: ACS reagent grade (36.5-38% w/w) MP Biomedicals (or
equivalent)
Ammonium Formate: Crystalline/Certified (100%)
Toxin Standards from the National Research Council (Halifax, Canada) or
equivalent: Saxitoxin (STX), neo-saxitoxin (NEO), decarbamoyl-saxitoxin (dcSTX), carbamoyl-gonyautoxin-1 & -4 (GTX-1 & -4), carbamoyl-gonyautoxin-2 & 3 (GTX-2 & -3)
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INSTRUMENTAL PARAMETERS
Instrument
A computer running MassLynx software version 1.2 (or equivalent) is used to
operate the LC/MS, to collect and analyze data. The chromatographic system
consists of a 2 um prefilter in line with a ZIC®-HILIC PEEK guard column (20 mm
x 2.1 mm I.D.) followed by a SeQuant ZIC®-HILIC analytical column (2.1 x
150mm PEEK, 3.5 urn, 200A).
HPLC Parameters:
Mobile phase reservoir A: Water
Mobile phase reservoir B: 15 mM ammonium formate/15 mM formic acid buffer at
pH3.8
Mobile phase reservoir C: Acetonitrile (LC/MS grade)
Flow rate: 0.2 ml/min
Column Temperature: 30 °C
Autosampler Temp: 15°C
Injection volume: 5 pi
Injection needle must be set to "1 mm" above inner vial when 200ul-vials are
used.
Gradient:
Time (min)

A (%)

B (%)

c (%)

0.00

18.0

18.0

64.0

5.00

18.0

30.0

52.0

10.00

2.0

50.0

48.0

20.00

2.0

50.0

48.0

20.10

18.0

18.0

64.0

30.00

18.0

18.0

64.0

Gradient method is a modified version of the method published by Diener'
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Mass Spectrometer Tuning Parameters:
SOURCE (ES+)

SETTINGS

Capillary (kV)

3.11

Cone (V)

30.00

Extractor (V)

3.00

RF Lens (V)

0.1

Source Temperature (°C)

130

Desolvation Temperature (°C)

450

Cone Gas Flow (L/Hr)

0

Desolvation Gas Flow (L/Hr)

650

ANALYZER

SETTINGS

LM 1 Resolution

8.1

LM 2 Resolution

16.2

Ion Energy

0.5

Multiplier

874

MS Method (Function 1: SIR of 10 masses, Time 0.00 to 30.00. ES+):
Type
SIR
Ion Mode

ES+

Data Format

Centroid

Scan Time (sec)

0.50

InterScan Time (sec)

0.10

Span (Da)

0.60

Start Time (min)

0.0

End Time (min)

30.0

Cone Voltage (V)

80.0

Ch

Mass (Da)

Dwell (s)

Cone (V)

Delay (s)

1

239.20

0.100

29.00

0.020

2

257.20

0.100

29.00

0.020

3

282.10

0.100

30.00

0.020

4

298.10

0.100

32.00

0.020

5

300.10

0.100

30.00

0.020

6

312.00

0.100

35.00

0.020

7

316.10

0.100

32.00

0.020

8

332.0

0.100

26.00

0.020

9

396.10

0.100

13.00

0.020

10

412.50

0.100

26.00

0.020
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OVERIEW OF PREPARATION PROCEDURES
Step 1: Preparation of reagents and toxin standard solutions
Step 2: Preparation of mussel extract
• Extraction procedure
• Clean-up procedure: preparation of Amicon tubes and mussel
extract
Step 3: Preparation of screening test
Step 4: Preparation samples for quantitative analysis

REAGENT PREPARATION PROCEDURES
HPLC Buffer (15 mM Formic acid/15 mM Ammonium Formate)
Weigh ~0.474g of ammonium formate salt into a 500 ml volumetric flask
half-filled with water
Pipet 286 ul of 99% formic acid into volumetric flask and bring to volume
with water
Filter buffer under vacuum using nylon filter paper for aqueous solvents
Solvent for Mussel and Toxin Standard Preparation (~0.003 M HCI)
Use 36.5 to 38 % HCI (equivalent to ~12M HCI) to prepare a stock HCI
solvent
To prepare a -0.3 M stock HCI, pipet 5 ml of ~12M HCI into a 100 ml
volumetric flask that is partially filled with water and bring to volume with water
To prepare -0.006 M HCI solution, pipet 10 ml of the -0.3M HCI solution
into a 500 volumetric flask that is partially filled with water and bring to volume
with water
To prepare -0.003 M HCI solution, pipet 10 ml of the -0.3 M solution into
a 1000 ml volumetric flask that is partially filled with water and bring to volume
with water
Solvent for Toxin Standard Preparation (0.003 M HCI + 0.01 M acetic acid)
Use the 17.4M acetic acid as to prepare a stock
To prepare 1.74M acetic acid stock solution, pipet 1 ml of the 17.4M acetic
acid into 10 ml volumetric flask that is partially filled with water and bring to
volume with water
To prepare for 10 ml of 0.17M acetic acid, pipet 1 ml of the 1.74M acetic
acid into 10 ml volumetric flask that is partially filled with water and bring to
volume with water
To prepare 0.02M acetic acid, pipet 11.5 ml of the 1.74M acetic acid into
1000 ml volumetric flask that is partially filled with water and bring to volume with
water
To prepare a solution containing 0.003 M HCI + 0.01 M acetic acid,
combine 0.02M acetic acid with an equal amount of -0.006 N HCI solution
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TOXIN STANDARDS PREPARATION
Each ampoule (-0.5 ml) should be allowed to warm to room temperature and
should be mixed thoroughly by inverting end-to-end prior to opening. Dilutions
should be made in minimal time to reduce evaporation of solvent from ampoule.
The remaining portion of standards in the ampoule should be transferred to a 2
ml autosampler vial with a 300-ul insert or storage vial with minimum headspace.
The vial cap should be sealed, wrapped with parafilm and stored in a freezer,
preferably at -20°C or lower. All dilutions should also be stored at -20°C or
lower. Toxin concentrations (in ppm) are calculated using molecular weights of
the salt form, described in the supplemental document written by NRC".

-0.5 mL

-0.5 ml_

-0.5 mL

-0.5 nriL

NRC CRMGTX2&3

NRC CRM-NEO

NRC CRM-STX

NRC CRMGTX1&4-C

NRC CRM-dcSTX -0.5 mL

Abbreviation

(60.4 uM, 19.7 uM)

27.0 ppm, 8.8 ppm

(65 uM in 0.5 mL)

24 ppm

(65 uM in0.5ml_)

25 ppm

(118uMand39uM)

46.6 ppm, 15 ppm

(62 uM in 0.5 mL)

20 ppm

Amount in Concentration in
ampoule ampoule

Preparation of Standard Toxins

3.2 ppm

Dilute 250 uL to 2 mL with
a solution containing 0.003
M HCI and 0.01 M acetic
acid
3.38 ppm, 1.1 ppm

Dilute 250 uL to 2.000 mL
3.0 ppm
with 0.003 M HCI

Dilute 250 uL to 2.000 ml
with 0.003 M HCI

Dilute 250 uL to 2.000 mL
with a solution containing
0.003 M HCI and 0.01 M
acetic acid
5.82 ppm, 1.9 ppm

Dilute 250 uL to 2.000 mL
with 0.003 M HCI
2.6 ppm

Prepare Stock Standard Suggested Stock
Concentration
solution
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SAMPLE PREPARATION AND EXTRACTION METHOD (To be done in a
fume hood)
Procedures (modified from the Food Microbiology document")
1. Choose 20-25 tightly closed and undamaged mussels
2. Clean off the debris and barnacles on the shell surface with a scrub brush
3. Cut open the shell with a shucking knife towards the hinged side of the
mussel, avoid cutting into the meat while shucking the inside open
Hinged side towards

4. Scrap off the entire piece of meat into a #10 sieve
5. Allow to drain for 5 minutes
6. Grind the meat in a blender at high speed for 60-120 seconds until
homogenous
7. Weigh 100 grams of homogenized meat into a tarred beaker
8. Record mass of homogenate
9. Mix homogenate with an equal amount (in weight) of 0.18 M HCI
10. Record mass of mixture
11. Heat the mixture to 100 degree Celsius for 5 minutes, with an evaporating
dish over the boiling beaker
12. Bring the mass back to the mass of the mixture from step 10 with 0.003 M
HCI
13. Centrifuge for 5 minutes at 3000 rpm and remove supernatant
14. Store supernatant (mussel extract) at -20°C or lower when not in use
SAMPLE CLEAN-UP METHOD (1.5 hours)
Procedures

'3

LoasC'.5 ml
HCI

Insert arc
Cap

Align and
centrifuge at
14.503 ram

(LEFTi Riraate
(RIGH1
UnfilterechCI

Invert device
irtotLbe

Centrifuge at
14.5D0 rpm
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Above diagrams illustrating procedures of rinsing Amicon were modified
from Amicon Ultra user manual'"
Pre-rinse Amicon device: Amicon Ultra device is composed of two parts:
the filter unit and the microcentrifuge tube.The ultrafiltration membranes in
filter unit contain trace amounts of glycerine. The unit should be rinsed by
loading 0.5 ml of ~0.003M HCI into the unit cell. Insert the filter unit into a
microcentrifuge tube. Place capped device into the centrifuge rotor. Align
the cap strap towards the center of the rotor. Counterbalance with another
device. Centrifuge at 14,500 rpm for approximately 30 minutes. To remove
the remaining solvent inside the filter unit, place this unit upside down into
the same centrifuge tube. Centrifuge for another 15 minutes to remove
solvent from the device. CAUTION: Be aware that the membrane in the
unit should not be allowed to dry out for a long period of time after rinsing.
Fluid should be left on the membrane until the device is used. Remove
and dispose of the tube containing rinsate and replace with a new clean
one. The pre-rinsed Amicon filter unit is now ready to be used for mussel
extract later on in this procedure.

Rinsed filter
device

New tube

Pre-rinsed Amicon device is now ready to be used for filtering extract.

2. Dilute 0.1 ml of mussel extract to 1 ml with -0.003M HCI for a dilution
factor of 10 (additional dilutions will be necessary for extract containing
high concentration of toxins, see "Shellfish Toxins Screening" section)
3. Load ~p.8 ml of diluted extract from step 2 into a regular 2 ml centrifuge
tubes (combine 0.2 ml of the diluted extract with 0.2 ml of toxin standard
mixture and load 0.4 ml of this spiked extract into another centrifuge tube,
see vial 7 in the "Sample Set" preparation section)

For quantitative analysis, not for screening process
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4. Centrifuge for 15 minutes at 14,500 rpm
5. Remove supernatant (clean extract) from centrifuge tube, discard the
remaining pellet on the bottom of the tube
6. Pull supernatant (approx. 0.6 ml) into a 1-ml disposable syringe; equip the
syringe tip with a syringe filter disc. Eject the liquid into the pre-rinsed
Amicon filter unit from step 1. Centrifuge at 14,500 rpm for 15 min to
extract filtration.
7. Collect clean extract for screening purpose as a "stock clean-up extract"
and/or make further dilutions if necessary for quantitative analysis
SHELLFISH TOXIN SCREENING
Screen collected clean extract by LC/MS to determine if any toxins are detected
If the S/N of the toxin peak is larger than 5, proceed with "QUANTITATIVE
ANALYSIS" the same day or immediately the day after (store at -20°C). Clean-up
procedures will be repeated as above and some modifications will be applied as
directed below.
Note that if proceeding to quantitative analysis, the concentration of toxins in the
original mussel must be below the maximum concentration of toxins on the linear
range of the standard calibration curve in order to be quantitated using a
standard addition curve. The table below indicates the estimated maximum
concentration of the most commonly found toxins allowed to be in the injected
extract and in the original mussel extract if 15 ppb STX and 16 pbb NEO
standard solution were used for spiking. The maximum concentrations can
change depending on the concentration of toxin standard spiked into the extract.
Note that the dilution factor used is 1:40. Standard addition curve is not
applicable for quantitation if the concentrations of toxins below exceed the
maximum of the calibrated range.
Max. Cone, of
toxins in original
mussel extract
(ppb)
1440

Cone, of toxin standard
used for spiking in a
standard addition
curve(ppb)

STX

Max. Cone, of
toxins in injected
mussel extract
(ppb)
36

NEO

37

1480

16

Toxins

15
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QUANTITATIVE ANALYSIS
Sample Set
1. Mussel extract
2. QC
3. Solvent Blank
4. Mussel extract
5. Mussel extract (low spike)
6. Mussel extract (high spike)
7. Mussel extract (high spike, before)
8. QC
Note:
QC - standard toxins in solvent
Solvent blank - 0.003 M HCI solvent
Mussel extract - diluted clean-up extract
5 , 6 - Toxin spiked mussel extract after clean-up procedures
7 - Spiked mussel with standard toxins (same cone, of toxins as in 6) before
clean-up procedures

Preparation of Sample Vials for Sample Set (in 300 ul vials)
2. QC
Prepare a toxin mix in concentrations within the calibrated linear range (a set
of saxitoxin, neo-saxitoxin and dc-saxitoxin or /and another set of all GTXs)
3. Solvent Blank
300 ul of HCI (-0.003M)
4. Mussel extract (same as 1.)
Add 100 ul of the stock cleaned-up extract from step 7 of the "Procedures"
(additional dilution may be necessary depending on the concentrations of
toxins) to 100 ul of 0.003M HCI solvent
5. Mussel extract (low spiked)
Combine 100 ul of the stock cleaned-up extract (additional dilution may be
necessary depending on the concentrations of the toxins) with100 ul of a
lower concentration of toxin mix (equal to or above LOQ, e.g. 3.0 ppb STX
and 3.2 ppb NEO)
6. Mussel extract (high spiked)
Combine 100 ul of the stock cleaned-up extract (more dilution may be
necessary depending on the concentration of the toxins) with 100 ul of a
higher concentration of the toxin mix (e.g. 30 ppb STX and 32 ppb NEO)
7. Mussel extract (high spiked, before)
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Add 200 ul of the mussel extract prepared from step 2 of th e"Procedures"
(the same dilution as the stock clean-up extract added to vials 4-6) into 200 ul
of the higher concentration of toxin mix (the same cone, added to vial 6)
Carry out "Procedures" from step 1 through step 7

CLEAN-UP
PROCEDURES

4. Spike 100 ul of
extract w/100 ul HCI

5. Spike 100 ul of
extract w/ 100 ul low
cone, of toxin

6. Spike 100 ul of
extract w/ 100 ul high
cone, of toxin

Spike 200 ul of
extract w /
200 ul of toxin

CLEAN-UP
PROCEDURES

7. Spiked extract w /
toxin BEFORE cleanup

DATA ANALYSIS
Displaying a Selected Ion Recording (Function 1 - SIR of 10 masses)
chromatogram with mass spectrum
• Highlight a file in the sample set browser
• Click "Chromatogram"
Extracting a SIR chromatogram for a specific m/z
• Go to "Display"
• Click "Mass"
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•
•

Double click "Channels", one of the ten channels from 1 to 10 with a
defined m/z
For example, double click on "5: 300.1" if STX is selected, then OK

Peak Area Integration
• Go to "Process"
• Select "Integrate"
• The peak area of interest should be highlighted
• To modify, go to "Edit", select "Integrated Peaks"
• Area count should appear on top of the peak along with a retention time
Check Signal-to-Noise Ratio
• Go to "Process"
• Select "Signal to Noise"
• Right click and drag along the entire length of the peak bottom, it should
go onto "Signal"
• Right click and drag along any baseline area, it should go onto "noise"
• Click "OK"
• The S/N ratio is displayed near the peak
•

Carry-Over Check
• Check chromatograms from vial 3 to determine if any toxins are carried
over from vial 2
• No carry-over should be observed
System Stability
• Calculate the % standard error from the signals for each toxin from vial 2
and 8
• The results must be within +/- 20% RSD
Standard Addition Curves
• Develop a 3-point curve for each toxin with the signals given for each toxin
from Vial 4 to 6
• Determine the concentration of each toxin in ppb by extrapolating the
curve to y=0 and multiplying x by the dilution factor
• R2 should be no less than 0.995
Percent Recovery
• Calculate the % recovery from signals obtained for each toxin from vials 6
and 7
• % Recovery of a toxin= (Toxin signal from vial 7)1 (Toxin signal from vial 6)
x100%
• % Recovery should be in the range of 80% to 120%
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Results
If any of the four tests fails the acceptable range or standard level, it is necessary
to prepare a new set of sample set for analysis starting from the sample clean-up
procedures with a new aliquot of the mussel extract.

ADDITIONAL INFORMATION
Retention Times of Toxins
Compound
Retention Time (min)

Quantifier m/z

Gonyautoxin 1 (GTX1)

9.7

332.0

Gonyautoxin 2 (GTX2)

9.9

316.1

Gonyautoxin 4 (GTX4)

12.9

412.5

Gonyautoxin 3 (GTX3)

13.5

396.1

Neo-Saxitoxin (NEO)

16.0

316.1

Saxitoxin (STX)

16.2

300.1

dc-Saxitoxin (dcSTX)

16.9

257.2

Retention time may vary within +/- 0.2 min.

Conversion of toxins in ppb (ng/ ml) to ug STX equivalents/100 g meat
Convert ppb value to Bioassay unit (ug STX equivalents/1 OOg mussel meat)
using the toxicity table from the supplemental document which is supplied with
the standard toxinslv
Toxin
dcSTX
GTX1
GTX2
GTX3
GTX4
NEO
STX

Relative Toxicity
0.5131
0.9940
0.3592
0.6379
0.7261
0.9243
1.0000
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For example, to convert 10 ppb STX and 20 ppb of NEO in a mussel sample to
Bioassay value, multiply 10 ppb STX by its toxicity factor, which is 1.0000 and
0.9243 to NEO. Thus,
Bioassay result= (10 ppb)(1.0000) + (20 ppb)(0.9243) = 28 ppb STX equivalents
= 2.8 ug STX equivalents/1 OOg mussel meat
Preliminary Studies of FDA and NRC STX Standards
It is noted that the FDA STX standard is being used for bioassay testing while the
NRC STX standard is being use for the LC/MS analysis. The assessment was
conducted to ensure that the concentrations of STX in the STX standards from
both providers are equivalent. In this investigation, the intensities of STX of the
STX standard obtained from FDA and NRC were compared to determine if the
stated concentrations were the same. The stated ratio of STX concentration in
the FDA STX to STX concentration in the NRC STX standards was calculated
from the concentrations stated on the Certificates of Analysis of toxin standards.
The experimental ratio was obtained by taking the ratio of the MS responses of
STX toxin peaks. Calculations were as follows:
nj_

^

,

^.

[STX]in the FDA STX standard

50 ppb

Stated ratio = -—„

.

Experimental ratio =
r

=

[STX]in the NRC STX standard
7.5 ppb
^ .
Intensity of STX in the FDA STX

^—^

-

Intensity of STX in the NRC STX

6.7

=—
1
5.5

=—
1

According to the PSP toxin supplemental document by Quilliam (1),
correction factors are established for mouse bioassay data calibrated against the
NRC calibration solution (F=1.00) and against the FDA solution (F= 1.16). The
fact that the correction factor for the FDA calibration solution is higher than that of
the NRC calibration solution, indicated that the STX response from the FDA STX
standard may be lower on the same stated concentration level with the NRC
STX. In that case, the correction factor (F= 1.16) can be used to compensate for
the loss of toxin responses from the FDA STX standard solution. The corrected
intensity can be obtained by multiplying the STX intensity in the FDA STX
standard by 1.16. Corrected experimental ratio is calculated by taking the ratio of
the corrected STX response of the FDA STX standard and the corrected STX
response of the NRC STX standard. The calculation is shown below:

6.3
Corrected experimental ratio = ——

The experimental ratio was corrected to 6.3/1 from 5.5/1, which resulted to be
higher and closer to the actual ratio of 6.7/1. The % error between the
experimental and the actual ratios is calculated to be -6.0%. It is also
acknowledged that results obtained for all mussel samples were analyzed by the
LC/MS method which employed NRC standards for quantification. As a result,
there may be a small discrepancy in total toxin levels obtained between the
bioassay test using the FDA STX standards and the LC/MS using the NRC STX
standards.
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Application of a new zwitterionic hydrophilic interaction chromatography column
for determination of paralytic shellfish poisoning toxins. Marc Diener, Katrin
Erier, Bernd Christian, Bernd Luckas. 1821-1826, Germany : J. Sep. Sci.,
2007, Vol. 30.
" Finnigan, Jayne S. Bioassay Procedure for Paralytical Shellfish Poisoning
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